BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 019179
(345 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1G0V|A Chain A, The Structure Of Proteinase A Complexed With A Ia3 Mutant,
Mvv
Length = 329
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 36/150 (24%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
NA Y I++GTPP + DTGS +W C C++ +D + SS+YK+
Sbjct: 12 NAQYYTDITLGTPPQNFKVILDTGSSNLWVPSNECGSLACFLHSK--YDHEASSSYKA-- 67
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTT------GQAVALPG 201
++++ YG GS G ++ +T+++G T +A + PG
Sbjct: 68 ----------------NGTEFAIQYGTGSLE-GYISQDTLSIGDLTIPKQDFAEATSEPG 110
Query: 202 ITFGCGTNNGGLFNSKTTGIVGLGGGDISL 231
+TF G K GI+GLG IS+
Sbjct: 111 LTFAFG---------KFDGILGLGYDTISV 131
>pdb|1DP5|A Chain A, The Structure Of Proteinase A Complexed With A Ia3 Mutant
Inhibitor
pdb|1DPJ|A Chain A, The Structure Of Proteinase A Complexed With Ia3 Peptide
Inhibitor
pdb|1FMU|A Chain A, Structure Of Native Proteinase A In P3221 Space Group.
pdb|1FMX|A Chain A, Structure Of Native Proteinase A In The Space Group P21
pdb|1FMX|B Chain B, Structure Of Native Proteinase A In The Space Group P21
Length = 329
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 36/150 (24%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
NA Y I++GTPP + DTGS +W C C++ +D + SS+YK+
Sbjct: 12 NAQYYTDITLGTPPQNFKVILDTGSSNLWVPSNECGSLACFLHSK--YDHEASSSYKA-- 67
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTT------GQAVALPG 201
++++ YG GS G ++ +T+++G T +A + PG
Sbjct: 68 ----------------NGTEFAIQYGTGSLE-GYISQDTLSIGDLTIPKQDFAEATSEPG 110
Query: 202 ITFGCGTNNGGLFNSKTTGIVGLGGGDISL 231
+TF G K GI+GLG IS+
Sbjct: 111 LTFAFG---------KFDGILGLGYDTISV 131
>pdb|2JXR|A Chain A, Structure Of Yeast Proteinase A
pdb|1FQ4|A Chain A, Crystal Structure Of A Complex Between Hydroxyethylene
Inhibitor Cp- 108,420 And Yeast Aspartic Proteinase A
pdb|1FQ5|A Chain A, X-Ray Struture Of A Cyclic Statine Inhibitor Pd-129,541
Bound To Yeast Proteinase A
pdb|1FQ6|A Chain A, X-Ray Structure Of Glycol Inhibitor Pd-133,450 Bound To
Saccharopepsin
pdb|1FQ7|A Chain A, X-Ray Structure Of Inhibitor Cp-72,647 Bound To
Saccharopepsin
pdb|1FQ8|A Chain A, X-Ray Structure Of Difluorostatine Inhibitor Cp81,198
Bound To Saccharopepsin
Length = 329
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 36/150 (24%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
NA Y I++GTPP + DTGS +W C C++ +D + SS+YK+
Sbjct: 12 NAQYYTDITLGTPPQNFKVILDTGSSNLWVPSNECGSLACFLHSK--YDHEASSSYKA-- 67
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTT------GQAVALPG 201
++++ YG GS G ++ +T+++G T +A + PG
Sbjct: 68 ----------------NGTEFAIQYGTGSLE-GYISQDTLSIGDLTIPKQDFAEATSEPG 110
Query: 202 ITFGCGTNNGGLFNSKTTGIVGLGGGDISL 231
+TF G K GI+GLG IS+
Sbjct: 111 LTFAFG---------KFDGILGLGYDTISV 131
>pdb|4AA9|A Chain A, Camel Chymosin At 1.6a Resolution
Length = 320
Score = 48.1 bits (113), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 44/140 (31%), Positives = 63/140 (45%), Gaps = 28/140 (20%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
++ Y +I IGTPP E V DTGS +W C + C ++ FDP+ SST+++L
Sbjct: 10 DSQYFGKIYIGTPPQEFTVVFDTGSSDLWVPSIYCKSNVC--KNHHRFDPRKSSTFRNL- 66
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTTGQAVALPGITFGCG 207
S+ YG GS G L +TVT+ + + P T G
Sbjct: 67 -----------------GKPLSIHYGTGSM-EGFLGYDTVTVSN-----IVDPNQTVGLS 103
Query: 208 TNN-GGLFN-SKTTGIVGLG 225
T G +F S+ GI+GL
Sbjct: 104 TEQPGEVFTYSEFDGILGLA 123
>pdb|1QDM|A Chain A, Crystal Structure Of Prophytepsin, A Zymogen Of A Barley
Vacuolar Aspartic Proteinase.
pdb|1QDM|B Chain B, Crystal Structure Of Prophytepsin, A Zymogen Of A Barley
Vacuolar Aspartic Proteinase.
pdb|1QDM|C Chain C, Crystal Structure Of Prophytepsin, A Zymogen Of A Barley
Vacuolar Aspartic Proteinase
Length = 478
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 46/151 (30%), Positives = 64/151 (42%), Gaps = 37/151 (24%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPS-QCYMQDSPLFDPKMSSTYKSL 146
NA Y I +GTPP + + DTGS +W C S CY+ + SSTYK
Sbjct: 51 NAQYFGEIGVGTPPQKFTVIFDTGSSNLWVPSAKCYFSIACYLHSR--YKAGASSTYKK- 107
Query: 147 PCSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTTG------QAVALP 200
N K ++ YG GS + G + ++VT+G +A P
Sbjct: 108 ----------NGKPA-------AIQYGTGSIA-GYFSEDSVTVGDLVVKDQEFIEATKEP 149
Query: 201 GITFGCGTNNGGLFNSKTTGIVGLGGGDISL 231
GITF +K GI+GLG +IS+
Sbjct: 150 GITF---------LVAKFDGILGLGFKEISV 171
>pdb|1UH7|A Chain A, Crystal Structure Of Rhizopuspepsin At Ph 4.6
pdb|1UH8|A Chain A, Crystal Structure Of Rhizopuspepsin At Ph 8.0
pdb|1UH9|A Chain A, Crystal Structure Of Rhizopuspepsin At Ph 7.0
Length = 325
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 41/159 (25%)
Query: 87 NNANYLIRISIGTPPTERLAVADTGSDLIW---TQCEPCPPSQCYMQDSPLFDPKMSSTY 143
N+ Y +++IGTP + DTGS +W T C C Q +DP SSTY
Sbjct: 13 NDIEYYGQVTIGTPGKKFNLDFDTGSSDLWIASTLCTNCGSRQTK------YDPNQSSTY 66
Query: 144 KSLPCSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGS--TTGQAVALP- 200
++ + +S+SYGDGS ++G LA + V LG GQ + L
Sbjct: 67 QADGRT------------------WSISYGDGSSASGILAKDNVNLGGLLIKGQTIELAK 108
Query: 201 --GITFGCGTNNGGLFNSKTTGIVGLGGGDISLISQMRT 237
+F G N+ G++GLG I+ + ++T
Sbjct: 109 REAASFASGPND---------GLLGLGFDTITTVRGVKT 138
>pdb|3APR|E Chain E, Binding Of A Reduced Peptide Inhibitor To The Aspartic
Proteinase From Rhizopus Chinensis. Implications For A
Mechanism Of Action
pdb|4APR|E Chain E, Structures Of Complexes Of Rhizopuspepsin With Pepstatin
And Other Statine-Containing Inhibitors
pdb|5APR|E Chain E, Structures Of Complexes Of Rhizopuspepsin With Pepstatin
And Other Statine-Containing Inhibitors
pdb|6APR|E Chain E, Structures Of Complexes Of Rhizopuspepsin With Pepstatin
And Other Statine-Containing Inhibitors
pdb|2APR|A Chain A, Structure And Refinement At 1.8 Angstroms Resolution Of
The Aspartic Proteinase From Rhizopus Chinensis
Length = 325
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 41/159 (25%)
Query: 87 NNANYLIRISIGTPPTERLAVADTGSDLIW---TQCEPCPPSQCYMQDSPLFDPKMSSTY 143
N+ Y +++IGTP + DTGS +W T C C Q +DP SSTY
Sbjct: 13 NDIEYYGQVTIGTPGKKFNLDFDTGSSDLWIASTLCTNCGSGQTK------YDPNQSSTY 66
Query: 144 KSLPCSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGS--TTGQAVALP- 200
++ + +S+SYGDGS ++G LA + V LG GQ + L
Sbjct: 67 QADGRT------------------WSISYGDGSSASGILAKDNVNLGGLLIKGQTIELAK 108
Query: 201 --GITFGCGTNNGGLFNSKTTGIVGLGGGDISLISQMRT 237
+F G N+ G++GLG I+ + ++T
Sbjct: 109 REAASFASGPND---------GLLGLGFDTITTVRGVKT 138
>pdb|1HTR|B Chain B, Crystal And Molecular Structures Of Human Progastricsin At
1.62 Angstroms Resolution
pdb|1AVF|A Chain A, Activation Intermediate 2 Of Human Gastricsin From Human
Stomach
pdb|1AVF|J Chain J, Activation Intermediate 2 Of Human Gastricsin From Human
Stomach
Length = 329
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 48/167 (28%), Positives = 72/167 (43%), Gaps = 29/167 (17%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+A Y ISIGTPP L + DTGS +W C C F+P SSTY
Sbjct: 11 DAAYFGEISIGTPPQNFLVLFDTGSSNLWVPSVYCQSQACTSHSR--FNPSESSTY---- 64
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTTGQAVALPGITFGCG 207
S N ++ +S+ YG GS + G +T+T+ Q++ +P FG
Sbjct: 65 -------STNGQT-------FSLQYGSGSLT-GFFGYDTLTV-----QSIQVPNQEFGLS 104
Query: 208 TNNGG--LFNSKTTGIVGLGGGDISLISQMRTTIAGNQRLGVSTPDI 252
N G ++ GI+GL +S + + T + G + G T +
Sbjct: 105 ENEPGTNFVYAQFDGIMGLAYPALS-VDEATTAMQGMVQEGALTSPV 150
>pdb|1CZI|E Chain E, Chymosin Complex With The Inhibitor Cp-113972
pdb|1CMS|A Chain A, The Three-Dimensional Structure Of Recombinant Bovine
Chymosin At 2.3 Angstroms Resolution
pdb|4CMS|A Chain A, X-Ray Analyses Of Aspartic Proteinases Iv. Structure And
Refinement At 2.2 Angstroms Resolution Of Bovine
Chymosin
pdb|4AA8|A Chain A, Bovine Chymosin At 1.8a Resolution
Length = 323
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 38/132 (28%), Positives = 56/132 (42%), Gaps = 27/132 (20%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
++ Y +I +GTPP E + DTGS W C + C ++ FDP+ SST+++L
Sbjct: 13 DSQYFGKIYLGTPPQEFTVLFDTGSSDFWVPSIYCKSNAC--KNHQRFDPRKSSTFQNL- 69
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGS------TTGQAVALPG 201
S+ YG GS G L +TVT+ + T G + PG
Sbjct: 70 -----------------GKPLSIHYGTGSM-QGILGYDTVTVSNIVDIQQTVGLSTQEPG 111
Query: 202 ITFGCGTNNGGL 213
F +G L
Sbjct: 112 DVFTYAEFDGIL 123
>pdb|1TZS|A Chain A, Crystal Structure Of An Activation Intermediate Of
Cathepsin E
Length = 351
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 43/143 (30%), Positives = 59/143 (41%), Gaps = 34/143 (23%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y ISIG+PP + DTGS +W C C F P SSTY S P
Sbjct: 22 DMEYFGTISIGSPPQNFTVIFDTGSSNLWVPSVYCTSPACKTHSR--FQPSQSSTY-SQP 78
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSN----GNLATETVT-LGSTTGQAVALPGI 202
S +S+ YG GS S ++ E +T +G G++V PG
Sbjct: 79 GQS-----------------FSIQYGTGSLSGIIGADQVSVEGLTVVGQQFGESVTEPGQ 121
Query: 203 TFGCGTNNGGLFNSKTTGIVGLG 225
TF +++ GI+GLG
Sbjct: 122 TF---------VDAEFDGILGLG 135
>pdb|3CMS|A Chain A, Engineering Enzyme Sub-Site Specificity: Preparation,
Kinetic Characterization And X-Ray Analysis At
2.0-Angstroms Resolution Of Val111phe Site-Mutated Calf
Chymosin
Length = 323
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 38/132 (28%), Positives = 56/132 (42%), Gaps = 27/132 (20%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
++ Y +I +GTPP E + DTGS W C + C ++ FDP+ SST+++L
Sbjct: 13 DSQYFGKIYLGTPPQEFTVLFDTGSSDFWVPSIYCKSNAC--KNHQRFDPRKSSTFQNL- 69
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGS------TTGQAVALPG 201
S+ YG GS G L +TVT+ + T G + PG
Sbjct: 70 -----------------GKPLSIHYGTGSM-QGILGYDTVTVSNIVDIQQTVGLSTQEPG 111
Query: 202 ITFGCGTNNGGL 213
F +G L
Sbjct: 112 DFFTYAEFDGIL 123
>pdb|3FV3|A Chain A, Secreted Aspartic Protease 1 From Candida Parapsilosis In
Complex With Pepstatin A
pdb|3FV3|B Chain B, Secreted Aspartic Protease 1 From Candida Parapsilosis In
Complex With Pepstatin A
pdb|3FV3|C Chain C, Secreted Aspartic Protease 1 From Candida Parapsilosis In
Complex With Pepstatin A
pdb|3FV3|D Chain D, Secreted Aspartic Protease 1 From Candida Parapsilosis In
Complex With Pepstatin A
pdb|3FV3|E Chain E, Secreted Aspartic Protease 1 From Candida Parapsilosis In
Complex With Pepstatin A
pdb|3FV3|F Chain F, Secreted Aspartic Protease 1 From Candida Parapsilosis In
Complex With Pepstatin A
pdb|3FV3|G Chain G, Secreted Aspartic Protease 1 From Candida Parapsilosis In
Complex With Pepstatin A
pdb|3FV3|H Chain H, Secreted Aspartic Protease 1 From Candida Parapsilosis In
Complex With Pepstatin A
pdb|3TNE|A Chain A, The Crystal Structure Of Protease Sapp1p From Candida
Parapsilosis In Complex With The Hiv Protease Inhibitor
Ritonavir
pdb|3TNE|B Chain B, The Crystal Structure Of Protease Sapp1p From Candida
Parapsilosis In Complex With The Hiv Protease Inhibitor
Ritonavir
Length = 339
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 33/120 (27%), Positives = 54/120 (45%), Gaps = 25/120 (20%)
Query: 84 IIPNNANYLIRISIGTPPTERLAVADTGSDLIW---TQCEPCPPSQCYMQDSPLFDPKMS 140
+I +Y ++S+G+ ++ + DTGS W + + C + S F P S
Sbjct: 7 LINEGPSYASKVSVGSNKQQQTVIIDTGSSDFWVVDSNAQCGKGVDC--KSSGTFTPSSS 64
Query: 141 STYKSLPCSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG--STTGQAVA 198
S+YK+L + +++ YGDGS S G +TVT+ S TGQ +A
Sbjct: 65 SSYKNLGAA------------------FTIRYGDGSTSQGTWGKDTVTINGVSITGQQIA 106
>pdb|2RMP|A Chain A, Rmp-Pepstatin A Complex
pdb|2ASI|A Chain A, Aspartic Proteinase
Length = 361
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 20/103 (19%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLPCSS 150
Y I +SIGTP + L + DTGS W + C S+ + S FDP SST+K+
Sbjct: 20 YAIPVSIGTPGQDFLLLFDTGSSDTWVPHKGCTKSEGCVG-SRFFDPSASSTFKA----- 73
Query: 151 SQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTT 193
N +++YG G +NG +++ +G T
Sbjct: 74 -------------TNYNLNITYGTGG-ANGLYFEDSIAIGDIT 102
>pdb|1AM5|A Chain A, The Crystal Structure And Proposed Amino Acid Sequence Of
A Pepsin From Atlantic Cod (Gadus Morhua)
Length = 324
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/96 (31%), Positives = 40/96 (41%), Gaps = 4/96 (4%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y ISIGTPP + DTGS +W C C + F P+ SSTY +
Sbjct: 11 DTEYYGVISIGTPPESFKVIFDTGSSNLWVSSSHCSAQACSNHNK--FKPRQSSTY--VE 66
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLA 183
+ + G+ Q +VS G GS N L
Sbjct: 67 TGKTVDLTYGTGGMRGILGQDTVSVGGGSDPNQELG 102
>pdb|1PPL|E Chain E, Crystallographic Analysis Of Transition-State Mimics Bound
To Penicillopepsin: Phosphorus-Containing Peptide
Analogues
pdb|1PPM|E Chain E, Crystallographic Analysis Of Transition-state Mimics Bound
To Penicillopepsin: Phosphorus-containing Peptide
Analogues
pdb|1APT|E Chain E, Crystallographic Analysis Of A Pepstatin Analogue Binding
To The Aspartyl Proteinase Penicillopepsin At 1.8
Angstroms Resolution
pdb|1APU|E Chain E, Crystallographic Analysis Of A Pepstatin Analogue Binding
To The Aspartyl Proteinase Penicillopepsin At 1.8
Angstroms Resolution
pdb|1APV|E Chain E, Crystallographic Analysis Of Transition State Mimics Bound
To Penicillopepsin: Difluorostatine-And
Difluorostatone-Containing Peptides
pdb|1APW|E Chain E, Crystallographic Analysis Of Transition State Mimics Bound
To Penicillopepsin: Difluorostatine-And
Difluorostatone-Containing Peptides
pdb|1PPK|E Chain E, Crystallographic Analysis Of Transition State Mimics Bound
To Penicillopepsin: Phosphorous-Containing Peptide
Analogues
pdb|1BXO|A Chain A, Acid Proteinase (Penicillopepsin) (E.C.3.4.23.20) Complex
With Phosphonate Inhibitor: Methyl
Cyclo[(2s)-2-[[(1r)-1-(N-(L-N-(3-
Methylbutanoyl)valyl-L-Aspartyl)amino)-3-Methylbut Yl]
Hydroxyphosphinyloxy]-3-(3-Aminomethyl) Phenylpropanoate
pdb|1BXQ|A Chain A, Acid Proteinase (Penicillopepsin) Complex With Phosphonate
Inhibitor.
pdb|2WEA|A Chain A, Acid Proteinase (Penicillopepsin) (E.C.3.4.23.20) Complex
With Phosphonate Inhibitor:
Methyl[cyclo-7[(2r)-((N-Valyl)
Amino)-2-(Hydroxyl-(1s)-1-Methyoxycarbonyl-2-
Phenylethoxy)
Phosphinyloxy-Ethyl]-1-Naphthaleneacetamide], Sodium
Salt
pdb|2WEB|A Chain A, Acid Proteinase (penicillopepsin) (e.c.3.4.23.20) Complex
With Phosphonate Inhibitor:
Methyl(2s)-[1-(((n-formyl)-l-
Valyl)amino-2-(2-naphthyl)ethyl)hydroxyphosphinyloxy]-3-
Phenylpropanoate, Sodium Salt
pdb|2WEC|A Chain A, Acid Proteinase (Penicillopepsin) (E.C.3.4.23.20) Complex
With Phosphonate Inhibitor: Methyl(2s)-[1-(((N-(1-
Naphthaleneacetyl))-L-Valyl)aminomethyl)hydroxy
Phosphinyloxy]-3-Phenylpropanoate, Sodium Salt
pdb|2WED|A Chain A, Acid Proteinase (penicillopepsin) (e.c.3.4.23.20) Complex
With Phosphonate Macrocyclic
Inhibitor:methyl[cyclo-7[(2r)-
((n-valyl)amino)-2-(hydroxyl-(1s)-1-methyoxycarbonyl-2-
Phenylethoxy)phosphinyloxy-ethyl]-1-
naphthaleneacetamide], Sodium Salt
pdb|3APP|A Chain A, Structure And Refinement Of Penicillopepsin At 1.8
Angstroms Resolution
Length = 323
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 43/133 (32%), Positives = 59/133 (44%), Gaps = 28/133 (21%)
Query: 87 NNANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
N+ Y+ ++IG T L DTGS +W P SQ +++P
Sbjct: 13 NDEEYITPVTIG-GTTLNLNF-DTGSADLWVFSTELPASQ--QSGHSVYNP--------- 59
Query: 147 PCSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTT--GQAVALP---G 201
S K SG +S+SYGDGS ++GN+ T++VT+G T GQAV
Sbjct: 60 --------SATGKELSGYT--WSISYGDGSSASGNVFTDSVTVGGVTAHGQAVQAAQQIS 109
Query: 202 ITFGCGTNNGGLF 214
F TNN GL
Sbjct: 110 AQFQQDTNNDGLL 122
>pdb|3VLB|A Chain A, Crystal Structure Of Xeg-Edgp
pdb|3VLB|C Chain C, Crystal Structure Of Xeg-Edgp
Length = 413
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 42/176 (23%), Positives = 73/176 (41%), Gaps = 36/176 (20%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLPCSS 150
Y+ I+ TP V D G +W C+ Q Y+ SSTY+ + C +
Sbjct: 22 YVTTINQRTPLVSENLVVDLGGRFLWVDCD-----QNYV----------SSTYRPVRCRT 66
Query: 151 SQCASLNQKSCS--------GVNCQYSVSYGDGSFSN----GNLATETVTL----GSTTG 194
SQC+ +C G N + + N G +A + V++ GS++G
Sbjct: 67 SQCSLSGSIACGDCFNGPRPGCNNNTCGVFPENPVINTATGGEVAEDVVSVESTDGSSSG 126
Query: 195 QAVALPGITFGCGTNNGGLFNSKTTGIVGLGG---GDISLISQMRTTIAGNQRLGV 247
+ V +P F C + L + +G+VG+ G I+L SQ + + ++ +
Sbjct: 127 RVVTVPRFIFSCAPTS--LLQNLASGVVGMAGLGRTRIALPSQFASAFSFKRKFAM 180
>pdb|3VLA|A Chain A, Crystal Structure Of Edgp
Length = 413
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 42/176 (23%), Positives = 73/176 (41%), Gaps = 36/176 (20%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLPCSS 150
Y+ I+ TP V D G +W C+ Q Y+ SSTY+ + C +
Sbjct: 22 YVTTINQRTPLVSENLVVDLGGRFLWVDCD-----QNYV----------SSTYRPVRCRT 66
Query: 151 SQCASLNQKSCS--------GVNCQYSVSYGDGSFSN----GNLATETVTL----GSTTG 194
SQC+ +C G N + + N G +A + V++ GS++G
Sbjct: 67 SQCSLSGSIACGDCFNGPRPGCNNNTCGVFPENPVINTATGGEVAEDVVSVESTDGSSSG 126
Query: 195 QAVALPGITFGCGTNNGGLFNSKTTGIVGLGG---GDISLISQMRTTIAGNQRLGV 247
+ V +P F C + L + +G+VG+ G I+L SQ + + ++ +
Sbjct: 127 RVVTVPRFIFSCAPTS--LLQNLASGVVGMAGLGRTRIALPSQFASAFSFKRKFAM 180
>pdb|1B5F|A Chain A, Native Cardosin A From Cynara Cardunculus L.
pdb|1B5F|C Chain C, Native Cardosin A From Cynara Cardunculus L
Length = 239
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 3/87 (3%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ +Y I IGTPP + + DTGS ++W C S+ S +++ SSTYK
Sbjct: 12 DTSYFGEIGIGTPPQKFTVIFDTGSSVLWVPSSKCINSKACRAHS-MYESSDSSTYKE-- 68
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGD 174
+ S +G Q SV+ GD
Sbjct: 69 NGTFGAIIYGTGSITGFFSQDSVTIGD 95
>pdb|3OAD|A Chain A, Design And Optimization Of New Piperidines As Renin
Inhibitors
pdb|3OAD|C Chain C, Design And Optimization Of New Piperidines As Renin
Inhibitors
pdb|3OAG|A Chain A, Design And Optimization Of New Piperidines As Renin
Inhibitors
pdb|3OAG|C Chain C, Design And Optimization Of New Piperidines As Renin
Inhibitors
pdb|3O9L|A Chain A, Design And Optimisation Of New Piperidines As Renin
Inhibitors
pdb|3O9L|C Chain C, Design And Optimisation Of New Piperidines As Renin
Inhibitors
Length = 166
Score = 37.7 bits (86), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 33/138 (23%), Positives = 50/138 (36%), Gaps = 23/138 (16%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTPP V DTGS +W C LFD SS+YK
Sbjct: 17 DTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYK--- 73
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTTGQAVALPGITFGCG 207
+ + + +YS G S + +T+ G+ +P + F
Sbjct: 74 -----------HNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFML- 121
Query: 208 TNNGGLFNSKTTGIVGLG 225
++ G+VG+G
Sbjct: 122 --------AEFDGVVGMG 131
>pdb|2I4Q|A Chain A, Human ReninPF02342674 COMPLEX
pdb|2I4Q|B Chain B, Human ReninPF02342674 COMPLEX
Length = 336
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 36/143 (25%), Positives = 54/143 (37%), Gaps = 33/143 (23%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTPP V DTGS +W C LFD SS+YK
Sbjct: 13 DTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKH-- 70
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTT-----GQAVALPGI 202
+ ++ Y G+ S G L+ + +T+G T G+ +P +
Sbjct: 71 ----------------NGTELTLRYSTGTVS-GFLSQDIITVGGITVTQMFGEVTEMPAL 113
Query: 203 TFGCGTNNGGLFNSKTTGIVGLG 225
F ++ G+VG+G
Sbjct: 114 PF---------MLAEFDGVVGMG 127
>pdb|2QZX|A Chain A, Secreted Aspartic Proteinase (Sap) 5 From Candida Albicans
pdb|2QZX|B Chain B, Secreted Aspartic Proteinase (Sap) 5 From Candida Albicans
Length = 342
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 11/103 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLPCSS 150
Y I++G+ + + DTGS +W P S + PK S+
Sbjct: 14 YTADITVGSDNQKLNVIVDTGSSDLW-----IPDSNV------ICIPKWRGDKGDFCKSA 62
Query: 151 SQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTT 193
+ + ++ +N ++ + YGDGS++ G L +TV +G +
Sbjct: 63 GSYSPASSRTSQNLNTRFDIKYGDGSYAKGKLYKDTVGIGGVS 105
>pdb|3D91|A Chain A, Human Renin In Complex With Remikiren
pdb|3D91|B Chain B, Human Renin In Complex With Remikiren
pdb|3G6Z|A Chain A, Design And Preparation Of Potent, Non-Peptidic,
Bioavailable Renin Inhibitors
pdb|3G6Z|B Chain B, Design And Preparation Of Potent, Non-Peptidic,
Bioavailable Renin Inhibitors
pdb|3G70|A Chain A, Design And Preparation Of Potent, Non-Peptidic,
Bioavailable Renin Inhibitors
pdb|3G70|B Chain B, Design And Preparation Of Potent, Non-Peptidic,
Bioavailable Renin Inhibitors
pdb|3K1W|A Chain A, New Classes Of Potent And Bioavailable Human Renin
Inhibitors
pdb|3K1W|B Chain B, New Classes Of Potent And Bioavailable Human Renin
Inhibitors
pdb|3OWN|A Chain A, Potent Macrocyclic Renin Inhibitors
pdb|3OWN|B Chain B, Potent Macrocyclic Renin Inhibitors
Length = 341
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 36/143 (25%), Positives = 54/143 (37%), Gaps = 33/143 (23%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTPP V DTGS +W C LFD SS+YK
Sbjct: 17 DTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKH-- 74
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTT-----GQAVALPGI 202
+ ++ Y G+ S G L+ + +T+G T G+ +P +
Sbjct: 75 ----------------NGTELTLRYSTGTVS-GFLSQDIITVGGITVTQMFGEVTEMPAL 117
Query: 203 TFGCGTNNGGLFNSKTTGIVGLG 225
F ++ G+VG+G
Sbjct: 118 PF---------MLAEFDGVVGMG 131
>pdb|1HRN|A Chain A, High Resolution Crystal Structures Of Recombinant Human
Renin In Complex With Polyhydroxymonoamide Inhibitors
pdb|1HRN|B Chain B, High Resolution Crystal Structures Of Recombinant Human
Renin In Complex With Polyhydroxymonoamide Inhibitors
pdb|1BIM|A Chain A, Crystallographic Studies On The Binding Modes Of P2-P3
Butanediamide Renin Inhibitors
pdb|1BIM|B Chain B, Crystallographic Studies On The Binding Modes Of P2-P3
Butanediamide Renin Inhibitors
pdb|1BIL|A Chain A, Crystallographic Studies On The Binding Modes Of P2-P3
Butanediamide Renin Inhibitors
pdb|1BIL|B Chain B, Crystallographic Studies On The Binding Modes Of P2-P3
Butanediamide Renin Inhibitors
pdb|3GW5|A Chain A, Crystal Structure Of Human Renin Complexed With A Novel
Inhibitor
pdb|3GW5|B Chain B, Crystal Structure Of Human Renin Complexed With A Novel
Inhibitor
pdb|3KM4|A Chain A, Optimization Of Orally Bioavailable Alkyl Amine Renin
Inhibitors
pdb|3KM4|B Chain B, Optimization Of Orally Bioavailable Alkyl Amine Renin
Inhibitors
Length = 337
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 36/143 (25%), Positives = 54/143 (37%), Gaps = 33/143 (23%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTPP V DTGS +W C LFD SS+YK
Sbjct: 14 DTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKH-- 71
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTT-----GQAVALPGI 202
+ ++ Y G+ S G L+ + +T+G T G+ +P +
Sbjct: 72 ----------------NGTELTLRYSTGTVS-GFLSQDIITVGGITVTQMFGEVTEMPAL 114
Query: 203 TFGCGTNNGGLFNSKTTGIVGLG 225
F ++ G+VG+G
Sbjct: 115 PF---------MLAEFDGVVGMG 128
>pdb|2G24|A Chain A, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
"c" Ring
pdb|2G24|B Chain B, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
"c" Ring
pdb|2G26|A Chain A, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
"c" Ring
pdb|2G26|B Chain B, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
"c" Ring
pdb|2G27|A Chain A, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
"c" Ring
pdb|2G27|B Chain B, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
"c" Ring
pdb|2FS4|A Chain A, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
C Ring
pdb|2FS4|B Chain B, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
C Ring
pdb|2G1N|A Chain A, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
"c" Ring
pdb|2G1N|B Chain B, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
"c" Ring
pdb|2G1O|A Chain A, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
"c" Ring
pdb|2G1O|B Chain B, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
"c" Ring
pdb|2G1R|A Chain A, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
C Ring
pdb|2G1R|B Chain B, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
C Ring
pdb|2G1S|A Chain A, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
C Ring
pdb|2G1S|B Chain B, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
C Ring
pdb|2G1Y|A Chain A, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
"c" Ring
pdb|2G1Y|B Chain B, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
"c" Ring
pdb|2G20|A Chain A, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
C Ring
pdb|2G20|B Chain B, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
C Ring
pdb|2G21|A Chain A, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
"c" Ring
pdb|2G21|B Chain B, Ketopiperazine-Based Renin Inhibitors: Optimization Of The
"c" Ring
pdb|2G22|A Chain A, Ketopiperazine-based Renin Inhibitors: Optimization Of The
"c" Ring
pdb|2G22|B Chain B, Ketopiperazine-based Renin Inhibitors: Optimization Of The
"c" Ring
Length = 333
Score = 37.4 bits (85), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 36/143 (25%), Positives = 54/143 (37%), Gaps = 33/143 (23%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTPP V DTGS +W C LFD SS+YK
Sbjct: 10 DTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKH-- 67
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTT-----GQAVALPGI 202
+ ++ Y G+ S G L+ + +T+G T G+ +P +
Sbjct: 68 ----------------NGTELTLRYSTGTVS-GFLSQDIITVGGITVTQMFGEVTEMPAL 110
Query: 203 TFGCGTNNGGLFNSKTTGIVGLG 225
F ++ G+VG+G
Sbjct: 111 PF---------MLAEFDGVVGMG 124
>pdb|2BKS|A Chain A, Crystal Structure Of Renin-Pf00074777 Complex
pdb|2BKS|B Chain B, Crystal Structure Of Renin-Pf00074777 Complex
pdb|2BKT|A Chain A, Crystal Structure Of Renin-Pf00257567 Complex
pdb|2BKT|B Chain B, Crystal Structure Of Renin-Pf00257567 Complex
pdb|2IKO|A Chain A, Crystal Structure Of Human Renin Complexed With Inhibitor
pdb|2IKO|B Chain B, Crystal Structure Of Human Renin Complexed With Inhibitor
pdb|2IKU|A Chain A, Crystal Structure Of Human Renin Complexed With Inhibitors
pdb|2IKU|B Chain B, Crystal Structure Of Human Renin Complexed With Inhibitors
pdb|2IL2|A Chain A, Crystal Structure Of Human Renin Complexed With Inhibitor
pdb|2IL2|B Chain B, Crystal Structure Of Human Renin Complexed With Inhibitor
pdb|2V0Z|C Chain C, Crystal Structure Of Renin With Inhibitor 10 (Aliskiren)
pdb|2V0Z|O Chain O, Crystal Structure Of Renin With Inhibitor 10 (Aliskiren)
pdb|2V10|C Chain C, Crystal Structure Of Renin With Inhibitor 9
pdb|2V10|O Chain O, Crystal Structure Of Renin With Inhibitor 9
pdb|2V11|C Chain C, Crystal Structure Of Renin With Inhibitor 6
pdb|2V11|O Chain O, Crystal Structure Of Renin With Inhibitor 6
pdb|2V12|C Chain C, Crystal Structure Of Renin With Inhibitor 8
pdb|2V12|O Chain O, Crystal Structure Of Renin With Inhibitor 8
pdb|1BBS|A Chain A, X-Ray Analyses Of Peptide Inhibitor Complexes Define The
Structural Basis Of Specificity For Human And Mouse
Renins
pdb|1BBS|B Chain B, X-Ray Analyses Of Peptide Inhibitor Complexes Define The
Structural Basis Of Specificity For Human And Mouse
Renins
pdb|1RNE|A Chain A, The Crystal Structure Of Recombinant Glycosylated Human
Renin Alone And In Complex With A Transition State
Analog Inhibitor
pdb|2REN|A Chain A, Structure Of Recombinant Human Renin, A Target For
Cardiovascular- Active Drugs, At 2.5 Angstroms
Resolution
pdb|2V13|A Chain A, Crystal Structure Of Renin With Inhibitor 7
pdb|2V16|C Chain C, Crystal Structure Of Renin With Inhibitor 3
pdb|2V16|O Chain O, Crystal Structure Of Renin With Inhibitor 3
pdb|3G72|A Chain A, Design And Preparation Of Potent, Non-Peptidic,
Bioavailable Renin Inhibitors
pdb|3G72|B Chain B, Design And Preparation Of Potent, Non-Peptidic,
Bioavailable Renin Inhibitors
pdb|3OQF|A Chain A, Crystal Structure Analysis Of Renin-Indole-Piperazine
Inhibitor Complexes
pdb|3OQF|B Chain B, Crystal Structure Analysis Of Renin-Indole-Piperazine
Inhibitor Complexes
pdb|3OOT|A Chain A, Crystal Structure Analysis Of Renin-Indole-Piperazin
Inhibitor Complexes
pdb|3OOT|B Chain B, Crystal Structure Analysis Of Renin-Indole-Piperazin
Inhibitor Complexes
pdb|3OQK|A Chain A, Crystal Structure Analysis Of Renin-Indole-Piperazin
Inhibitor Complexes
pdb|3OQK|B Chain B, Crystal Structure Analysis Of Renin-Indole-Piperazin
Inhibitor Complexes
pdb|3Q3T|A Chain A, Alkyl Amine Renin Inhibitors: Filling S1 From S3
pdb|3Q3T|B Chain B, Alkyl Amine Renin Inhibitors: Filling S1 From S3
pdb|3SFC|A Chain A, Structure-Based Optimization Of Potent 4- And
6-Azaindole-3- Carboxamides As Renin Inhibitors
pdb|3SFC|B Chain B, Structure-Based Optimization Of Potent 4- And
6-Azaindole-3- Carboxamides As Renin Inhibitors
pdb|3Q4B|A Chain A, Clinically Useful Alkyl Amine Renin Inhibitors
pdb|3Q4B|B Chain B, Clinically Useful Alkyl Amine Renin Inhibitors
pdb|3Q5H|A Chain A, Clinically Useful Alkyl Amine Renin Inhibitors
pdb|3Q5H|B Chain B, Clinically Useful Alkyl Amine Renin Inhibitors
pdb|3VSW|A Chain A, Human Renin In Complex With Compound 8
pdb|3VSW|B Chain B, Human Renin In Complex With Compound 8
pdb|3VSX|A Chain A, Human Renin In Complex With Compound 18
pdb|3VSX|B Chain B, Human Renin In Complex With Compound 18
pdb|3VYD|A Chain A, Human Renin In Complex With Inhibitor 6
pdb|3VYD|B Chain B, Human Renin In Complex With Inhibitor 6
pdb|3VYE|A Chain A, Human Renin In Complex With Inhibitor 7
pdb|3VYE|B Chain B, Human Renin In Complex With Inhibitor 7
pdb|3VYF|A Chain A, Human Renin In Complex With Inhibitor 9
pdb|3VYF|B Chain B, Human Renin In Complex With Inhibitor 9
pdb|4GJ8|A Chain A, Crystal Structure Of Renin In Complex With Pkf909-724
(compound 3)
pdb|4GJ8|B Chain B, Crystal Structure Of Renin In Complex With Pkf909-724
(compound 3)
pdb|4GJ9|A Chain A, Crystal Structure Of Renin In Complex With Gp055321
(compound 4)
pdb|4GJ9|B Chain B, Crystal Structure Of Renin In Complex With Gp055321
(compound 4)
pdb|4GJA|A Chain A, Crystal Structure Of Renin In Complex With Nvp-ayl747
(compound 5)
pdb|4GJA|B Chain B, Crystal Structure Of Renin In Complex With Nvp-ayl747
(compound 5)
pdb|4GJB|A Chain A, Crystal Structure Of Renin In Complex With Nvp-bbv031
(compound 6)
pdb|4GJB|B Chain B, Crystal Structure Of Renin In Complex With Nvp-bbv031
(compound 6)
pdb|4GJC|A Chain A, Crystal Structure Of Renin In Complex With Nvp-bch965
(compound 9)
pdb|4GJC|B Chain B, Crystal Structure Of Renin In Complex With Nvp-bch965
(compound 9)
pdb|4GJD|A Chain A, Crystal Structure Of Renin In Complex With Nvp-bgq311
(compound 12)
pdb|4GJD|B Chain B, Crystal Structure Of Renin In Complex With Nvp-bgq311
(compound 12)
Length = 340
Score = 37.4 bits (85), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 36/143 (25%), Positives = 54/143 (37%), Gaps = 33/143 (23%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTPP V DTGS +W C LFD SS+YK
Sbjct: 17 DTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKH-- 74
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTT-----GQAVALPGI 202
+ ++ Y G+ S G L+ + +T+G T G+ +P +
Sbjct: 75 ----------------NGTELTLRYSTGTVS-GFLSQDIITVGGITVTQMFGEVTEMPAL 117
Query: 203 TFGCGTNNGGLFNSKTTGIVGLG 225
F ++ G+VG+G
Sbjct: 118 PF---------MLAEFDGVVGMG 131
>pdb|1WKR|A Chain A, Crystal Structure Of Aspartic Proteinase From Irpex
Lacteus
Length = 340
Score = 37.4 bits (85), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 37/142 (26%), Positives = 62/142 (43%), Gaps = 40/142 (28%)
Query: 90 NYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLPCS 149
+Y++ + +G+P T + DTGS W + + Y++ S
Sbjct: 13 DYVVNVGVGSPATTYSLLVDTGSSNTWLGAD-----KSYVKTS----------------- 50
Query: 150 SSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTTGQAVALPGITFGCGTN 209
+ S + + SV+YG GSFS G T+TVTLGS T +P + G +
Sbjct: 51 ----------TSSATSDKVSVTYGSGSFS-GTEYTDTVTLGSLT-----IPKQSIGVASR 94
Query: 210 NGGLFNSKTTGIVGLGGGDISL 231
+ G GI+G+G D+++
Sbjct: 95 DSGF--DGVDGILGVGPVDLTV 114
>pdb|3VCM|A Chain A, Crystal Structure Of Human Prorenin
pdb|3VCM|B Chain B, Crystal Structure Of Human Prorenin
Length = 335
Score = 37.4 bits (85), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 36/143 (25%), Positives = 54/143 (37%), Gaps = 33/143 (23%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTPP V DTGS +W C LFD SS+YK
Sbjct: 17 DTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKH-- 74
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTT-----GQAVALPGI 202
+ ++ Y G+ S G L+ + +T+G T G+ +P +
Sbjct: 75 ----------------NGTELTLRYSTGTVS-GFLSQDIITVGGITVTQMFGEVTEMPAL 117
Query: 203 TFGCGTNNGGLFNSKTTGIVGLG 225
F ++ G+VG+G
Sbjct: 118 PF---------MLAEFDGVVGMG 131
>pdb|2X0B|A Chain A, Crystal Structure Of Human Angiotensinogen Complexed With
Renin
pdb|2X0B|C Chain C, Crystal Structure Of Human Angiotensinogen Complexed With
Renin
pdb|2X0B|E Chain E, Crystal Structure Of Human Angiotensinogen Complexed With
Renin
pdb|2X0B|G Chain G, Crystal Structure Of Human Angiotensinogen Complexed With
Renin
Length = 383
Score = 37.4 bits (85), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 36/143 (25%), Positives = 54/143 (37%), Gaps = 33/143 (23%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTPP V DTGS +W C LFD SS+YK
Sbjct: 60 DTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKH-- 117
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTT-----GQAVALPGI 202
+ ++ Y G+ S G L+ + +T+G T G+ +P +
Sbjct: 118 ----------------NGTELTLRYSTGTVS-GFLSQDIITVGGITVTQMFGEVTEMPAL 160
Query: 203 TFGCGTNNGGLFNSKTTGIVGLG 225
F ++ G+VG+G
Sbjct: 161 PFML---------AEFDGVVGMG 174
>pdb|1IBQ|A Chain A, Aspergillopepsin From Aspergillus Phoenicis
pdb|1IBQ|B Chain B, Aspergillopepsin From Aspergillus Phoenicis
Length = 325
Score = 36.6 bits (83), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 54/113 (47%), Gaps = 25/113 (22%)
Query: 87 NNANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
N+ YL +++G T L DTGS +W + P S+ D L+ P S+T
Sbjct: 12 NDEEYLTPVTVG-KSTLHLDF-DTGSADLWVFSDELPSSEQTGHD--LYTPSSSAT---- 63
Query: 147 PCSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG--STTGQAV 197
SG + + +SYGDGS ++G++ +TVT+G +T QAV
Sbjct: 64 -------------KLSGYS--WDISYGDGSSASGDVYRDTVTVGGVTTNKQAV 101
>pdb|2H6S|A Chain A, Secreted Aspartic Proteinase (sap) 3 From Candida Albicans
pdb|2H6T|A Chain A, Secreted Aspartic Proteinase (Sap) 3 From Candida Albicans
Complexed With Pepstatin A
Length = 340
Score = 36.6 bits (83), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 46/110 (41%), Gaps = 18/110 (16%)
Query: 84 IIPNNANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDP---KMS 140
+I +Y I++G+ + V DTGS +W P SQ Q DP K
Sbjct: 7 LINEQVSYASDITVGSNKQKLTVVIDTGSSDLW-----VPDSQVSCQAGQGQDPNFCKNE 61
Query: 141 STYKSLPCSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG 190
TY SSSQ +N +S+ YGDG+ S G +T+ G
Sbjct: 62 GTYSPSSSSSSQ----------NLNSPFSIEYGDGTTSQGTWYKDTIGFG 101
>pdb|1MPP|A Chain A, X-Ray Analyses Of Aspartic Proteinases. V. Structure And
Refinement At 2.0 Angstroms Resolution Of The Aspartic
Proteinase From Mucor Pusillus
Length = 361
Score = 36.2 bits (82), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 46/104 (44%), Gaps = 22/104 (21%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQ-CYMQDSPLFDPKMSSTYKSLPCS 149
Y I +SIGTP + + DTGS W + C S+ C + FDP SST+K
Sbjct: 20 YAIPVSIGTPGQDFYLLFDTGSSDTWVPHKGCDNSEGCVGK--RFFDPSSSSTFKE---- 73
Query: 150 SSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTT 193
+ +++YG G +NG +++T+G T
Sbjct: 74 --------------TDYNLNITYGTGG-ANGIYFRDSITVGGAT 102
>pdb|3PSG|A Chain A, The High Resolution Crystal Structure Of Porcine
Pepsinogen
Length = 370
Score = 35.8 bits (81), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 42/141 (29%), Positives = 60/141 (42%), Gaps = 32/141 (22%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTP + + DTGS +W C C D F+P SST++
Sbjct: 55 DTEYFGTIGIGTPAQDFTVIFDTGSSNLWVPSVYCSSLAC--SDHNQFNPDDSSTFE--- 109
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG--STTGQAVALPGITFG 205
++SQ + S++YG GS + G L +TV +G S T Q FG
Sbjct: 110 -ATSQ--------------ELSITYGTGSMT-GILGYDTVQVGGISDTNQ-------IFG 146
Query: 206 CGTNNGG--LFNSKTTGIVGL 224
G L+ + GI+GL
Sbjct: 147 LSETEPGSFLYYAPFDGILGL 167
>pdb|1PSA|A Chain A, Structure Of A Pepsin(Slash)renin Inhibitor Complex
Reveals A Novel Crystal Packing Induced By Minor
Chemical Alterations In The Inhibitor
pdb|1PSA|B Chain B, Structure Of A Pepsin(Slash)renin Inhibitor Complex
Reveals A Novel Crystal Packing Induced By Minor
Chemical Alterations In The Inhibitor
pdb|1YX9|A Chain A, Effect Of Dimethyl Sulphoxide On The Crystal Structure Of
Porcine Pepsin
Length = 326
Score = 35.8 bits (81), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 35/114 (30%), Positives = 50/114 (43%), Gaps = 23/114 (20%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTP + + DTGS +W C C D F+P SST++
Sbjct: 11 DTEYFGTIGIGTPAQDFTVIFDTGSSNLWVPSVYCSSLAC--SDHNQFNPDDSSTFE--- 65
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG--STTGQAVAL 199
++SQ + S++YG GS + G L +TV +G S T Q L
Sbjct: 66 -ATSQ--------------ELSITYGTGSMT-GILGYDTVQVGGISDTNQIFGL 103
>pdb|1FLH|A Chain A, Crystal Structure Of Human Uropepsin At 2.45 A Resolution
Length = 326
Score = 35.8 bits (81), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 36/114 (31%), Positives = 50/114 (43%), Gaps = 23/114 (20%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTP + V DTGS +W C C + F+P+ SSTY+
Sbjct: 11 DMEYFGTIGIGTPAQDFTVVFDTGSSNLWVPSVYCSSLACTNHNR--FNPEDSSTYQ--- 65
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG--STTGQAVAL 199
S+S+ S++YG GS + G L +TV +G S T Q L
Sbjct: 66 -STSETV--------------SITYGTGSMT-GILGYDTVQVGGISDTNQIFGL 103
>pdb|1PSO|E Chain E, The Crystal Structure Of Human Pepsin And Its Complex With
Pepstatin
pdb|1QRP|E Chain E, Human Pepsin 3a In Complex With A Phosphonate Inhibitor
Iva-Val-Val- Leu(P)-(O)phe-Ala-Ala-Ome
pdb|1PSN|A Chain A, The Crystal Structure Of Human Pepsin And Its Complex With
Pepstatin
pdb|3UTL|A Chain A, Human Pepsin 3b
Length = 326
Score = 35.8 bits (81), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 36/114 (31%), Positives = 50/114 (43%), Gaps = 23/114 (20%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTP + V DTGS +W C C + F+P+ SSTY+
Sbjct: 11 DMEYFGTIGIGTPAQDFTVVFDTGSSNLWVPSVYCSSLACTNHNR--FNPEDSSTYQ--- 65
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG--STTGQAVAL 199
S+S+ S++YG GS + G L +TV +G S T Q L
Sbjct: 66 -STSETV--------------SITYGTGSMT-GILGYDTVQVGGISDTNQIFGL 103
>pdb|5PEP|A Chain A, X-Ray Analyses Of Aspartic Proteases. Ii.
Three-Dimensional Structure Of The Hexagonal Crystal
Form Of Porcine Pepsin At 2.3 Angstroms Resolution
Length = 326
Score = 35.8 bits (81), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 35/114 (30%), Positives = 50/114 (43%), Gaps = 23/114 (20%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTP + + DTGS +W C C D F+P SST++
Sbjct: 11 DTEYFGTIGIGTPAQDFTVIFDTGSSNLWVPSVYCSSLAC--SDHNQFNPDDSSTFE--- 65
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG--STTGQAVAL 199
++SQ + S++YG GS + G L +TV +G S T Q L
Sbjct: 66 -ATSQ--------------ELSITYGTGSMT-GILGYDTVQVGGISDTNQIFGL 103
>pdb|3PEP|A Chain A, Revised 2.3 Angstroms Structure Of Porcine Pepsin.
Evidence For A Flexible Subdomain
Length = 326
Score = 35.4 bits (80), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 35/114 (30%), Positives = 50/114 (43%), Gaps = 23/114 (20%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTP + + DTGS +W C C D F+P SST++
Sbjct: 11 DTEYFGTIGIGTPAQDFTVIFDTGSSNLWVPSVYCSSLAC--SDHNQFNPDDSSTFE--- 65
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG--STTGQAVAL 199
++SQ + S++YG GS + G L +TV +G S T Q L
Sbjct: 66 -ATSQ--------------ELSITYGTGSMT-GILGYDTVQVGGISDTNQIFGL 103
>pdb|1ZAP|A Chain A, Secreted Aspartic Protease From C. Albicans
Length = 342
Score = 35.4 bits (80), Expect = 0.053, Method: Compositional matrix adjust.
Identities = 29/100 (29%), Positives = 41/100 (41%), Gaps = 11/100 (11%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLPCSS 150
Y I++G+ + + DTGS +W Y + F K TY S+
Sbjct: 14 YAADITVGSNNQKLNVIVDTGSSDLWVPDVNIDCQVTYSDQTADF-CKQKGTYDPSGSSA 72
Query: 151 SQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG 190
SQ +N +S+ YGDGS S G L +TV G
Sbjct: 73 SQ----------DLNTPFSIGYGDGSSSQGTLYKDTVGFG 102
>pdb|2PSG|A Chain A, Refined Structure Of Porcine Pepsinogen At 1.8 Angstroms
Resolution
Length = 370
Score = 35.0 bits (79), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 40/141 (28%), Positives = 57/141 (40%), Gaps = 32/141 (22%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTP + + DTGS +W C C D F+P SST+++
Sbjct: 55 DTEYFGTIGIGTPAQDFTVIFDTGSSNLWVPSVYCSSLAC--SDHNQFNPDDSSTFEA-- 110
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG--STTGQAVALPGITFG 205
+ S++YG GS + G L +TV +G S T Q FG
Sbjct: 111 ----------------TXQELSITYGTGSMT-GILGYDTVQVGGISDTNQ-------IFG 146
Query: 206 CGTNNGG--LFNSKTTGIVGL 224
G L+ + GI+GL
Sbjct: 147 LSETEPGSFLYYAPFDGILGL 167
>pdb|1F34|A Chain A, Crystal Structure Of Ascaris Pepsin Inhibitor-3 Bound To
Porcine Pepsin
Length = 326
Score = 34.7 bits (78), Expect = 0.080, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 47/114 (41%), Gaps = 23/114 (20%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTP + + DTGS +W C C D F+P SST+++
Sbjct: 11 DTEYFGTIGIGTPAQDFTVIFDTGSSNLWVPSVYCSSLAC--SDHNQFNPDDSSTFEA-- 66
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG--STTGQAVAL 199
+ S++YG GS + G L +TV +G S T Q L
Sbjct: 67 ----------------TXQELSITYGTGSMT-GILGYDTVQVGGISDTNQIFGL 103
>pdb|4PEP|A Chain A, The Molecular And Crystal Structures Of Monoclinic Porcine
Pepsin Refined At 1.8 Angstroms Resolution
Length = 326
Score = 34.7 bits (78), Expect = 0.083, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 47/114 (41%), Gaps = 23/114 (20%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLP 147
+ Y I IGTP + + DTGS +W C C D F+P SST+++
Sbjct: 11 DTEYFGTIGIGTPAQDFTVIFDTGSSNLWVPSVYCSSLAC--SDHNQFNPDDSSTFEA-- 66
Query: 148 CSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG--STTGQAVAL 199
+ S++YG GS + G L +TV +G S T Q L
Sbjct: 67 ----------------TXQELSITYGTGSMT-GILGYDTVQVGGISDTNQIFGL 103
>pdb|2QZW|A Chain A, Secreted Aspartic Proteinase (Sap) 1 From Candida Albicans
pdb|2QZW|B Chain B, Secreted Aspartic Proteinase (Sap) 1 From Candida Albicans
Length = 341
Score = 34.7 bits (78), Expect = 0.089, Method: Compositional matrix adjust.
Identities = 32/120 (26%), Positives = 50/120 (41%), Gaps = 27/120 (22%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWT-----QCEPCPPSQC--YMQDSPLFDPKMS 140
+ +Y I+IG+ + + DTGS +W C+ P Q + + ++ PK S
Sbjct: 11 HVSYAADITIGSNKQKFNVIVDTGSSDLWVPDASVTCDKPRPGQSADFCKGKGIYTPKSS 70
Query: 141 STYKSLPCSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG--STTGQAVA 198
+T ++L + + YGDGS S G L +TV G S T Q A
Sbjct: 71 TTSQNL------------------GTPFYIGYGDGSSSQGTLYKDTVGFGGASITKQVFA 112
>pdb|1J71|A Chain A, Structure Of The Extracellular Aspartic Proteinase From
Candida Tropicalis Yeast
Length = 334
Score = 34.7 bits (78), Expect = 0.090, Method: Compositional matrix adjust.
Identities = 30/107 (28%), Positives = 45/107 (42%), Gaps = 11/107 (10%)
Query: 84 IIPNNANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTY 143
+I +Y I +G+ ++ V DTGS +W Y + F K T+
Sbjct: 7 LINEGPSYAADIVVGSNQQKQTVVIDTGSSDLWVVDTDAECQVTYSGQTNNF-CKQEGTF 65
Query: 144 KSLPCSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG 190
P SSS +LNQ +S+ YGD + S G+ +TV G
Sbjct: 66 D--PSSSSSAQNLNQ--------DFSIEYGDLTSSQGSFYKDTVGFG 102
>pdb|1EAG|A Chain A, Secreted Aspartic Proteinase (Sap2) From Candida Albicans
Complexed With A70450
pdb|3PVK|A Chain A, Secreted Aspartic Protease 2 In Complex With Benzamidine
pdb|3Q70|A Chain A, Secreted Aspartic Protease In Complex With Ritonavir
Length = 342
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 40/100 (40%), Gaps = 11/100 (11%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLPCSS 150
Y I++G+ + + DTGS +W Y + F K TY S+
Sbjct: 14 YAADITVGSNNQKLNVIVDTGSSDLWVPDVNVDCQVTYSDQTADF-CKQKGTYDPSGSSA 72
Query: 151 SQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG 190
SQ +N + + YGDGS S G L +TV G
Sbjct: 73 SQ----------DLNTPFKIGYGDGSSSQGTLYKDTVGFG 102
>pdb|1IZD|A Chain A, Crystal Structure Of Aspergillus Oryzae Aspartic
Proteinase
pdb|1IZE|A Chain A, Crystal Structure Of Aspergillus Oryzae Aspartic
Proteinase Complexed With Pepstatin
Length = 323
Score = 32.3 bits (72), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 27/105 (25%), Positives = 46/105 (43%), Gaps = 25/105 (23%)
Query: 87 NNANYLIRISIGTPPTERLAVA-DTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKS 145
N+ Y+ ++++G + L + DTGS +W P S+ D
Sbjct: 13 NDEEYITQVTVGD---DTLGLDFDTGSADLWVFSSQTPSSERSGHD------------YY 57
Query: 146 LPCSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLG 190
P SS+Q +S+SYGDGS ++G++ + VT+G
Sbjct: 58 TPGSSAQKID---------GATWSISYGDGSSASGDVYKDKVTVG 93
>pdb|1SMR|A Chain A, The 3-D Structure Of Mouse Submaxillary Renin Complexed
With A Decapeptide Inhibitor Ch-66 Based On The 4-16
Fragment Of Rat Angiotensinogen
pdb|1SMR|C Chain C, The 3-D Structure Of Mouse Submaxillary Renin Complexed
With A Decapeptide Inhibitor Ch-66 Based On The 4-16
Fragment Of Rat Angiotensinogen
pdb|1SMR|E Chain E, The 3-D Structure Of Mouse Submaxillary Renin Complexed
With A Decapeptide Inhibitor Ch-66 Based On The 4-16
Fragment Of Rat Angiotensinogen
pdb|1SMR|G Chain G, The 3-D Structure Of Mouse Submaxillary Renin Complexed
With A Decapeptide Inhibitor Ch-66 Based On The 4-16
Fragment Of Rat Angiotensinogen
Length = 335
Score = 32.3 bits (72), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 36/133 (27%), Positives = 53/133 (39%), Gaps = 28/133 (21%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQ--DSPLFDPKMSSTYKS 145
N+ Y I IGTPP + DTGS +W C S+ Y+ L++ SS+Y
Sbjct: 14 NSQYYGEIGIGTPPQTFKVIFDTGSANLWVPSTKC--SRLYLACGIHSLYESSDSSSYME 71
Query: 146 LPCSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTT-----GQAVALP 200
+++ YG G G L+ ++VT+G T G+ LP
Sbjct: 72 ------------------NGDDFTIHYGSGRV-KGFLSQDSVTVGGITVTQTFGEVTQLP 112
Query: 201 GITFGCGTNNGGL 213
I F +G L
Sbjct: 113 LIPFMLAQFDGVL 125
>pdb|3AUP|A Chain A, Crystal Structure Of Basic 7s Globulin From Soybean
pdb|3AUP|B Chain B, Crystal Structure Of Basic 7s Globulin From Soybean
pdb|3AUP|C Chain C, Crystal Structure Of Basic 7s Globulin From Soybean
pdb|3AUP|D Chain D, Crystal Structure Of Basic 7s Globulin From Soybean
Length = 403
Score = 31.2 bits (69), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 43/159 (27%), Positives = 57/159 (35%), Gaps = 39/159 (24%)
Query: 99 TPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLPCSSSQCASLNQ 158
TP + + D + +W CE Q Y S TY++ C S+QC+ N
Sbjct: 31 TPLMQVPVLVDLNGNHLWVNCE-----QQYS----------SKTYQAPFCHSTQCSRANT 75
Query: 159 KSC------SGVNCQYSV-----------SYGDGSFSNGNLATETVTLGSTT--GQAVAL 199
C S C + G G LA T GST G V +
Sbjct: 76 HQCLSCPAASRPGCHKNTCGLMSTNPITQQTGLGELGEDVLAIH-ATQGSTQQLGPLVTV 134
Query: 200 PGITFGCGTN---NGGLFNSKTTGIVGLGGGDISLISQM 235
P F C + GL T G+ GLG ISL +Q+
Sbjct: 135 PQFLFSCAPSFLVQKGL-PRNTQGVAGLGHAPISLPNQL 172
>pdb|1LYW|A Chain A, Cathepsin D At Ph 7.5
pdb|1LYW|C Chain C, Cathepsin D At Ph 7.5
pdb|1LYW|E Chain E, Cathepsin D At Ph 7.5
pdb|1LYW|G Chain G, Cathepsin D At Ph 7.5
pdb|1LYA|A Chain A, Crystal Structures Of Native And Inhibited Forms Of Human
Cathepsin D: Implications For Lysosomal Targeting And
Drug Design
pdb|1LYA|C Chain C, Crystal Structures Of Native And Inhibited Forms Of Human
Cathepsin D: Implications For Lysosomal Targeting And
Drug Design
pdb|1LYB|A Chain A, Crystal Structures Of Native And Inhibited Forms Of Human
Cathepsin D: Implications For Lysosomal Targeting And
Drug Design
pdb|1LYB|C Chain C, Crystal Structures Of Native And Inhibited Forms Of Human
Cathepsin D: Implications For Lysosomal Targeting And
Drug Design
Length = 97
Score = 30.4 bits (67), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 42/104 (40%), Gaps = 23/104 (22%)
Query: 88 NANYLIRISIGTPPTERLAVADTGSDLIWTQCEPCP--PSQCYMQDSPLFDPKMSSTYKS 145
+A Y I IGTPP V DTGS +W C C++ ++ SSTY
Sbjct: 12 DAQYYGEIGIGTPPQCFTVVFDTGSSNLWVPSIHCKLLDIACWIHHK--YNSDKSSTYVK 69
Query: 146 LPCSSSQCASLNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTL 189
S + + YG GS S G L+ +TV++
Sbjct: 70 NGTS------------------FDIHYGSGSLS-GYLSQDTVSV 94
>pdb|1MIQ|A Chain A, Crystal Structure Of Proplasmepsin From The Human Malarial
Pathogen Plasmodium Vivax
pdb|1MIQ|B Chain B, Crystal Structure Of Proplasmepsin From The Human Malarial
Pathogen Plasmodium Vivax
Length = 375
Score = 29.6 bits (65), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 35/140 (25%), Positives = 64/140 (45%), Gaps = 31/140 (22%)
Query: 96 SIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLPCSSSQCAS 155
+G + + + DTGS +W + C S C +++ L+D S +Y
Sbjct: 69 EVGDNHQKFMLIFDTGSANLWVPSKKCNSSGCSIKN--LYDSSKSKSY------------ 114
Query: 156 LNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTTGQAVALPGITFGCGTNNGGL-- 213
+K + V+ ++YG G+ G + + VTLG +++P F T+ L
Sbjct: 115 --EKDGTKVD----ITYGSGTVK-GFFSKDLVTLGH-----LSMP-YKFIEVTDTDDLEP 161
Query: 214 -FNS-KTTGIVGLGGGDISL 231
++S + GI+GLG D+S+
Sbjct: 162 IYSSVEFDGILGLGWKDLSI 181
>pdb|1SGZ|A Chain A, Crystal Structure Of Unbound Beta-Secretase Catalytic
Domain.
pdb|1SGZ|B Chain B, Crystal Structure Of Unbound Beta-Secretase Catalytic
Domain.
pdb|1SGZ|C Chain C, Crystal Structure Of Unbound Beta-Secretase Catalytic
Domain.
pdb|1SGZ|D Chain D, Crystal Structure Of Unbound Beta-Secretase Catalytic
Domain.
pdb|1XS7|D Chain D, Crystal Structure Of A Cycloamide-Urethane-Derived Novel
Inhibitor Bound To Human Brain Memapsin 2
(Beta-Secretase).
pdb|1XN2|A Chain A, New Substrate Binding Pockets For Beta-Secretase.
pdb|1XN2|B Chain B, New Substrate Binding Pockets For Beta-Secretase.
pdb|1XN2|C Chain C, New Substrate Binding Pockets For Beta-Secretase.
pdb|1XN2|D Chain D, New Substrate Binding Pockets For Beta-Secretase.
pdb|1XN3|A Chain A, Crystal Structure Of Beta-Secretase Bound To A Long
Inhibitor With Additional Upstream Residues.
pdb|1XN3|B Chain B, Crystal Structure Of Beta-Secretase Bound To A Long
Inhibitor With Additional Upstream Residues.
pdb|1XN3|C Chain C, Crystal Structure Of Beta-Secretase Bound To A Long
Inhibitor With Additional Upstream Residues.
pdb|1XN3|D Chain D, Crystal Structure Of Beta-Secretase Bound To A Long
Inhibitor With Additional Upstream Residues.
pdb|2G94|A Chain A, Crystal Structure Of Beta-secretase Bound To A Potent And
Highly Selective Inhibitor.
pdb|2G94|B Chain B, Crystal Structure Of Beta-secretase Bound To A Potent And
Highly Selective Inhibitor.
pdb|2G94|C Chain C, Crystal Structure Of Beta-secretase Bound To A Potent And
Highly Selective Inhibitor.
pdb|2G94|D Chain D, Crystal Structure Of Beta-secretase Bound To A Potent And
Highly Selective Inhibitor.
pdb|2P4J|A Chain A, Crystal Structure Of Beta-Secretase Bond To An Inhibitor
With Isophthalamide Derivatives At P2-P3
pdb|2P4J|B Chain B, Crystal Structure Of Beta-Secretase Bond To An Inhibitor
With Isophthalamide Derivatives At P2-P3
pdb|2P4J|C Chain C, Crystal Structure Of Beta-Secretase Bond To An Inhibitor
With Isophthalamide Derivatives At P2-P3
pdb|2P4J|D Chain D, Crystal Structure Of Beta-Secretase Bond To An Inhibitor
With Isophthalamide Derivatives At P2-P3
pdb|2VKM|A Chain A, Crystal Structure Of Grl-8234 Bound To Bace
(Beta-Secretase)
pdb|2VKM|B Chain B, Crystal Structure Of Grl-8234 Bound To Bace
(Beta-Secretase)
pdb|2VKM|C Chain C, Crystal Structure Of Grl-8234 Bound To Bace
(Beta-Secretase)
pdb|2VKM|D Chain D, Crystal Structure Of Grl-8234 Bound To Bace
(Beta-Secretase)
pdb|3UFL|A Chain A, Discovery Of Pyrrolidine-Based B-Secretase Inhibitors:
Lead Advancement Through Conformational Design For
Maintenance Of Ligand Binding Efficiency
Length = 389
Score = 29.6 bits (65), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 18 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 67
>pdb|2FDP|A Chain A, Crystal Structure Of Beta-Secretase Complexed With An
Amino- Ethylene Inhibitor
pdb|2FDP|B Chain B, Crystal Structure Of Beta-Secretase Complexed With An
Amino- Ethylene Inhibitor
pdb|2FDP|C Chain C, Crystal Structure Of Beta-Secretase Complexed With An
Amino- Ethylene Inhibitor
pdb|3IXJ|A Chain A, Crystal Structure Of Beta-Secretase 1 In Complex With
Selective Beta-Secretase 1 Inhibitor
pdb|3IXJ|B Chain B, Crystal Structure Of Beta-Secretase 1 In Complex With
Selective Beta-Secretase 1 Inhibitor
pdb|3IXJ|C Chain C, Crystal Structure Of Beta-Secretase 1 In Complex With
Selective Beta-Secretase 1 Inhibitor
pdb|4GID|A Chain A, Structure Of Beta-Secretase Complexed With Inhibitor
pdb|4GID|B Chain B, Structure Of Beta-Secretase Complexed With Inhibitor
pdb|4GID|C Chain C, Structure Of Beta-Secretase Complexed With Inhibitor
pdb|4GID|D Chain D, Structure Of Beta-Secretase Complexed With Inhibitor
Length = 388
Score = 29.3 bits (64), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 17 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 66
>pdb|2QK5|A Chain A, Structure Of Bace1 Bound To Sch626485
pdb|2QK5|B Chain B, Structure Of Bace1 Bound To Sch626485
pdb|2QMD|A Chain A, Structure Of Bace Bound To Sch722924
pdb|2QMD|B Chain B, Structure Of Bace Bound To Sch722924
pdb|2QMF|A Chain A, Structure Of Bace Bound To Sch735310
pdb|2QMF|B Chain B, Structure Of Bace Bound To Sch735310
pdb|2QP8|A Chain A, Structure Of Bace Bound To Sch734723
pdb|2QP8|B Chain B, Structure Of Bace Bound To Sch734723
pdb|2QMG|A Chain A, Structure Of Bace Bound To Sch745966
pdb|2QMG|B Chain B, Structure Of Bace Bound To Sch745966
Length = 395
Score = 29.3 bits (64), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 23 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 72
>pdb|4B1D|A Chain A, New Aminoimidazoles As Bace-1 Inhibitors: From Rational
Design To Ab-Lowering In Brain
pdb|4B1E|A Chain A, New Aminoimidazoles As Bace-1 Inhibitors: From Rational
Design To Ab-Lowering In Brain
Length = 388
Score = 29.3 bits (64), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 18 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 67
>pdb|3U6A|A Chain A, Rational Design And Synthesis Of Aminopiperazinones As
Beta Secretase (Bace) Inhibitors
pdb|3U6A|B Chain B, Rational Design And Synthesis Of Aminopiperazinones As
Beta Secretase (Bace) Inhibitors
pdb|3U6A|C Chain C, Rational Design And Synthesis Of Aminopiperazinones As
Beta Secretase (Bace) Inhibitors
Length = 390
Score = 29.3 bits (64), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 19 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 68
>pdb|3R1G|B Chain B, Structure Basis Of Allosteric Inhibition Of Bace1 By An
Exosite- Binding Antibody
Length = 402
Score = 29.3 bits (64), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 21 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 70
>pdb|3CIB|A Chain A, Structure Of Bace Bound To Sch727596
pdb|3CIB|B Chain B, Structure Of Bace Bound To Sch727596
pdb|3CIC|A Chain A, Structure Of Bace Bound To Sch709583
pdb|3CIC|B Chain B, Structure Of Bace Bound To Sch709583
pdb|3CID|A Chain A, Structure Of Bace Bound To Sch726222
pdb|3CID|B Chain B, Structure Of Bace Bound To Sch726222
pdb|4FS4|A Chain A, Structure Of Bace Bound To
(S)-4-(3'-Methoxy-[1,1'-Biphenyl]-3-Yl)-1,
4-Dimethyl-6-Oxotetrahydropyrimidin-2(1h)-Iminium
pdb|4FS4|B Chain B, Structure Of Bace Bound To
(S)-4-(3'-Methoxy-[1,1'-Biphenyl]-3-Yl)-1,
4-Dimethyl-6-Oxotetrahydropyrimidin-2(1h)-Iminium
Length = 390
Score = 29.3 bits (64), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 18 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 67
>pdb|1FKN|A Chain A, Structure Of Beta-Secretase Complexed With Inhibitor
pdb|1FKN|B Chain B, Structure Of Beta-Secretase Complexed With Inhibitor
pdb|1M4H|A Chain A, Crystal Structure Of Beta-Secretase Complexed With
Inhibitor Om00-3
pdb|1M4H|B Chain B, Crystal Structure Of Beta-Secretase Complexed With
Inhibitor Om00-3
Length = 391
Score = 29.3 bits (64), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 20 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 69
>pdb|4DPF|A Chain A, Bace-1 In Complex With A Hea-Macrocyclic Type Inhibitor
pdb|4DPI|A Chain A, Bace-1 In Complex With Hea-Macrocyclic Inhibitor, Mv078512
Length = 391
Score = 29.3 bits (64), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 20 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 69
>pdb|3KMX|A Chain A, Structure Of Bace Bound To Sch346572
pdb|3KMX|B Chain B, Structure Of Bace Bound To Sch346572
pdb|3KMY|A Chain A, Structure Of Bace Bound To Sch12472
pdb|3KMY|B Chain B, Structure Of Bace Bound To Sch12472
pdb|3KN0|A Chain A, Structure Of Bace Bound To Sch708236
pdb|3KN0|B Chain B, Structure Of Bace Bound To Sch708236
pdb|3LNK|A Chain A, Structure Of Bace Bound To Sch743813
pdb|3LNK|B Chain B, Structure Of Bace Bound To Sch743813
pdb|4FRS|A Chain A, Structure Of Bace In Complex With
(S)-4-(3-Chloro-5-(5-(Prop-1-Yn-1-
Yl)pyridin-3-Yl)thiophen-2-Yl)-1,
4-Dimethyl-6-Oxotetrahydropyrimidin- 2(1h)-Iminium
pdb|4FRS|B Chain B, Structure Of Bace In Complex With
(S)-4-(3-Chloro-5-(5-(Prop-1-Yn-1-
Yl)pyridin-3-Yl)thiophen-2-Yl)-1,
4-Dimethyl-6-Oxotetrahydropyrimidin- 2(1h)-Iminium
Length = 395
Score = 29.3 bits (64), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 23 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 72
>pdb|2WJO|A Chain A, Human Bace (Beta Secretase) In Complex With
Cyclohexanecarboxylic Acid (2-(2-Am Ino-6-Phenoxy-4h-
Quinazolin-3-Yl)-2-Cyclohexyl-Ethyl)-Amide
Length = 412
Score = 29.3 bits (64), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 18 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 67
>pdb|4EWO|A Chain A, Design And Synthesis Of Potent Hydroxyethylamine (Hea)
Bace-1 Inhibitors
pdb|4EXG|A Chain A, Design And Synthesis Of Potent Hydroxyethylamine (Hea)
Bace-1 Inhibitors
Length = 386
Score = 29.3 bits (64), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 15 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 64
>pdb|3UDH|A Chain A, Crystal Structure Of Bace With Compound 1
pdb|3UDJ|A Chain A, Crystal Structure Of Bace With Compound 5
pdb|3UDK|A Chain A, Crystal Structure Of Bace With Compound 6
pdb|3UDM|A Chain A, Crystal Structure Of Bace With Compound 8
pdb|3UDN|A Chain A, Crystal Structure Of Bace With Compound 9
pdb|3UDP|A Chain A, Crystal Structure Of Bace With Compound 12
pdb|3UDQ|A Chain A, Crystal Structure Of Bace With Compound 13
pdb|3UDR|A Chain A, Crystal Structure Of Bace With Compound 14
pdb|3UDY|A Chain A, Crystal Structure Of Bace With Compound 11
pdb|4FM7|A Chain A, Crystal Structure Of Bace With Compound 14g
pdb|4FM8|A Chain A, Crystal Structure Of Bace With Compound 12a
Length = 404
Score = 29.3 bits (64), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 18 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 67
>pdb|3TPJ|A Chain A, Apo Structure Of Bace1
pdb|3TPL|A Chain A, Apo Structure Of Bace1
pdb|3TPL|B Chain B, Apo Structure Of Bace1
pdb|3TPL|C Chain C, Apo Structure Of Bace1
pdb|3TPP|A Chain A, Crystal Structure Of Bace1 Complexed With An Inhibitor
pdb|3UQP|A Chain A, Crystal Structure Of Bace1 With Its Inhibitor
pdb|3UQU|A Chain A, Crystal Structure Of Bace1 With Its Inhibitor
pdb|3UQW|A Chain A, Crystal Structure Of Bace1 With Its Inhibitor
pdb|3UQX|A Chain A, Crystal Structure Of Bace1 With Its Inhibitor
pdb|4DV9|A Chain A, Crystal Structure Of Bace1 With Its Inhibitor
pdb|4DVF|A Chain A, Crystal Structure Of Bace1 With Its Inhibitor
pdb|4DVF|B Chain B, Crystal Structure Of Bace1 With Its Inhibitor
pdb|4FGX|A Chain A, Crystal Structure Of Bace1 With Novel Inhibitor
Length = 433
Score = 29.3 bits (64), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 54 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 103
>pdb|2QZL|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Ixs
Length = 411
Score = 29.3 bits (64), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 40 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 89
>pdb|1YM2|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Nvp-Aur200
pdb|1YM2|B Chain B, Crystal Structure Of Human Beta Secretase Complexed With
Nvp-Aur200
pdb|1YM2|C Chain C, Crystal Structure Of Human Beta Secretase Complexed With
Nvp-Aur200
pdb|2F3E|A Chain A, Crystal Structure Of The Bace Complex With Axq093, A
Macrocyclic Inhibitor
pdb|2F3E|B Chain B, Crystal Structure Of The Bace Complex With Axq093, A
Macrocyclic Inhibitor
pdb|2F3E|C Chain C, Crystal Structure Of The Bace Complex With Axq093, A
Macrocyclic Inhibitor
pdb|2F3F|A Chain A, Crystal Structure Of The Bace Complex With Bdf488, A
Macrocyclic Inhibitor
pdb|2F3F|B Chain B, Crystal Structure Of The Bace Complex With Bdf488, A
Macrocyclic Inhibitor
pdb|2F3F|C Chain C, Crystal Structure Of The Bace Complex With Bdf488, A
Macrocyclic Inhibitor
pdb|3DUY|A Chain A, Crystal Structure Of Human Beta-Secretase In Complex With
Nvp-Afj144
pdb|3DUY|B Chain B, Crystal Structure Of Human Beta-Secretase In Complex With
Nvp-Afj144
pdb|3DUY|C Chain C, Crystal Structure Of Human Beta-Secretase In Complex With
Nvp-Afj144
pdb|3DV1|A Chain A, Crystal Structure Of Human Beta-Secretase In Complex With
Nvp-Arv999
pdb|3DV1|B Chain B, Crystal Structure Of Human Beta-Secretase In Complex With
Nvp-Arv999
pdb|3DV1|C Chain C, Crystal Structure Of Human Beta-Secretase In Complex With
Nvp-Arv999
pdb|3DV5|A Chain A, Crystal Structure Of Human Beta-Secretase In Complex With
Nvp-Bav544
pdb|3DV5|B Chain B, Crystal Structure Of Human Beta-Secretase In Complex With
Nvp-Bav544
pdb|3DV5|C Chain C, Crystal Structure Of Human Beta-Secretase In Complex With
Nvp-Bav544
pdb|3K5C|A Chain A, Human Bace-1 Complex With Nb-216
pdb|3K5C|B Chain B, Human Bace-1 Complex With Nb-216
pdb|3K5C|C Chain C, Human Bace-1 Complex With Nb-216
pdb|3K5F|A Chain A, Human Bace-1 Complex With Ayh011
pdb|3K5F|B Chain B, Human Bace-1 Complex With Ayh011
pdb|3K5F|C Chain C, Human Bace-1 Complex With Ayh011
pdb|3K5G|A Chain A, Human Bace-1 Complex With Bjc060
pdb|3K5G|B Chain B, Human Bace-1 Complex With Bjc060
pdb|3K5G|C Chain C, Human Bace-1 Complex With Bjc060
pdb|3PI5|A Chain A, Crystal Structure Of Human Beta Secretase In Complex With
Bfg356
pdb|3PI5|B Chain B, Crystal Structure Of Human Beta Secretase In Complex With
Bfg356
pdb|3PI5|C Chain C, Crystal Structure Of Human Beta Secretase In Complex With
Bfg356
pdb|3QBH|A Chain A, Structure Based Design, Synthesis And Sar Of Cyclic
Hydroxyethylamine (Hea) Bace-1 Inhibitors
pdb|3QBH|B Chain B, Structure Based Design, Synthesis And Sar Of Cyclic
Hydroxyethylamine (Hea) Bace-1 Inhibitors
pdb|3QBH|C Chain C, Structure Based Design, Synthesis And Sar Of Cyclic
Hydroxyethylamine (Hea) Bace-1 Inhibitors
pdb|3VEU|A Chain A, Crystal Structure Of Human Beta Secretase In Complex With
Nvp-Avi326
pdb|3VF3|A Chain A, Crystal Structure Of Human Beta Secretase In Complex With
Nvp-Bqq711
pdb|3VG1|A Chain A, Crystal Structure Of Human Beta Secretase In Complex With
Nvp-Bur436, Derived From A Soaking Experiment
pdb|4D83|A Chain A, Crystal Structure Of Human Beta Secretase In Complex With
Nvp-Bur436, Derived From A Co-Crystallization Experiment
pdb|4D83|B Chain B, Crystal Structure Of Human Beta Secretase In Complex With
Nvp-Bur436, Derived From A Co-Crystallization Experiment
pdb|4D83|C Chain C, Crystal Structure Of Human Beta Secretase In Complex With
Nvp-Bur436, Derived From A Co-Crystallization Experiment
pdb|4D88|A Chain A, Crystal Structure Of Human Beta Secretase In Complex With
Nvp-Bxq490
pdb|4D89|A Chain A, Crystal Structure Of Human Beta Secretase In Complex With
Nvp-Bxd552, Derived From A Soaking Experiment
pdb|4D8C|A Chain A, Crystal Structure Of Human Beta Secretase In Complex With
Nvp-Bxd552, Derived From A Co-Crystallization Experiment
pdb|4D8C|B Chain B, Crystal Structure Of Human Beta Secretase In Complex With
Nvp-Bxd552, Derived From A Co-Crystallization Experiment
pdb|4D8C|C Chain C, Crystal Structure Of Human Beta Secretase In Complex With
Nvp-Bxd552, Derived From A Co-Crystallization Experiment
Length = 402
Score = 29.3 bits (64), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 30 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 79
>pdb|3LPI|A Chain A, Structure Of Bace Bound To Sch745132
pdb|3LPI|B Chain B, Structure Of Bace Bound To Sch745132
pdb|3LPJ|A Chain A, Structure Of Bace Bound To Sch743641
pdb|3LPJ|B Chain B, Structure Of Bace Bound To Sch743641
pdb|3LPK|A Chain A, Structure Of Bace Bound To Sch747123
pdb|3LPK|B Chain B, Structure Of Bace Bound To Sch747123
pdb|3OHF|A Chain A, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-655295 Aka N~3~-((1s,2r)-1-
Benzyl-2-Hydroxy-3-((3-
Methoxybenzyl)amino)propyl)-N~1~,
N~1~-Dibutyl-1h-Indole-1,3- Dicarboxamide
pdb|3OHF|B Chain B, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-655295 Aka N~3~-((1s,2r)-1-
Benzyl-2-Hydroxy-3-((3-
Methoxybenzyl)amino)propyl)-N~1~,
N~1~-Dibutyl-1h-Indole-1,3- Dicarboxamide
pdb|3OHH|A Chain A, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-681889 Aka
N~1~-Butyl-5-Cyano- N~3~-((1s,2r)-1-(3,5-
Difluorobenzyl)-2-Hydroxy-3-((3-
Methoxybenzyl)amino)propyl)-N~1~- Methyl-1h-Indole-1,3-
Dicarboxamide
pdb|3OHH|B Chain B, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-681889 Aka
N~1~-Butyl-5-Cyano- N~3~-((1s,2r)-1-(3,5-
Difluorobenzyl)-2-Hydroxy-3-((3-
Methoxybenzyl)amino)propyl)-N~1~- Methyl-1h-Indole-1,3-
Dicarboxamide
pdb|3R2F|A Chain A, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-693391 Aka
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-((1s,2r)-1-(3,
5-Difluorobenzyl)-2-Hydroxy-2-((2r,4r)-
4-Propoxy-2-Pyrrolidinyl)ethyl)-4-Phenylbutanamide
pdb|3R2F|B Chain B, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-693391 Aka
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-((1s,2r)-1-(3,
5-Difluorobenzyl)-2-Hydroxy-2-((2r,4r)-
4-Propoxy-2-Pyrrolidinyl)ethyl)-4-Phenylbutanamide
pdb|3R2F|D Chain D, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-693391 Aka
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-((1s,2r)-1-(3,
5-Difluorobenzyl)-2-Hydroxy-2-((2r,4r)-
4-Propoxy-2-Pyrrolidinyl)ethyl)-4-Phenylbutanamide
pdb|3R2F|E Chain E, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With Bms-693391 Aka
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-((1s,2r)-1-(3,
5-Difluorobenzyl)-2-Hydroxy-2-((2r,4r)-
4-Propoxy-2-Pyrrolidinyl)ethyl)-4-Phenylbutanamide
pdb|3SKF|A Chain A, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With
(2s)-2-((3s)-3-(Acetylamino)-3-(Butan-2-Yl)-2-
Oxopyrrolidin-1-
Yl)-N-((2s,
3r)-3-Hydroxy-4-((3-Methoxybenzyl)amino)-1-Phenylbutan-
2- Yl)-4-Phenylbutanamide
pdb|3SKF|B Chain B, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With
(2s)-2-((3s)-3-(Acetylamino)-3-(Butan-2-Yl)-2-
Oxopyrrolidin-1-
Yl)-N-((2s,
3r)-3-Hydroxy-4-((3-Methoxybenzyl)amino)-1-Phenylbutan-
2- Yl)-4-Phenylbutanamide
pdb|3SKG|A Chain A, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-
((1s,2r)-1-(3,5-Difluorobenzyl)-2-Hydroxy-2-(1,2,3,
4-Tetrahydro-3- Isoquinolinyl)ethyl)-4-Phenylbutanamide
pdb|3SKG|B Chain B, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-
((1s,2r)-1-(3,5-Difluorobenzyl)-2-Hydroxy-2-(1,2,3,
4-Tetrahydro-3- Isoquinolinyl)ethyl)-4-Phenylbutanamide
pdb|3SKG|D Chain D, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-
((1s,2r)-1-(3,5-Difluorobenzyl)-2-Hydroxy-2-(1,2,3,
4-Tetrahydro-3- Isoquinolinyl)ethyl)-4-Phenylbutanamide
pdb|3SKG|E Chain E, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With
(2s)-2-((3r)-3-Acetamido-3-Isobutyl-2-Oxo-1-
Pyrrolidinyl)-N-
((1s,2r)-1-(3,5-Difluorobenzyl)-2-Hydroxy-2-(1,2,3,
4-Tetrahydro-3- Isoquinolinyl)ethyl)-4-Phenylbutanamide
pdb|4FSE|A Chain A, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With N-(N-(4-Amino-3,5-
Dichlorobenzyl)carbamimidoyl)-3-(4- Methoxyphenyl)-5-
Methyl-4-Isothiazolecarboxamide
pdb|4FSE|B Chain B, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With N-(N-(4-Amino-3,5-
Dichlorobenzyl)carbamimidoyl)-3-(4- Methoxyphenyl)-5-
Methyl-4-Isothiazolecarboxamide
pdb|4FSE|D Chain D, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With N-(N-(4-Amino-3,5-
Dichlorobenzyl)carbamimidoyl)-3-(4- Methoxyphenyl)-5-
Methyl-4-Isothiazolecarboxamide
pdb|4FSE|E Chain E, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Wt) Complex With N-(N-(4-Amino-3,5-
Dichlorobenzyl)carbamimidoyl)-3-(4- Methoxyphenyl)-5-
Methyl-4-Isothiazolecarboxamide
Length = 455
Score = 29.3 bits (64), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 76 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 125
>pdb|2HM1|A Chain A, Crystal Structure Of Human Beta-Secretase (Bace) In The
Presence Of An Inhibitor (2)
pdb|2IQG|A Chain A, Crystal Structure Of Hydroxyethyl Secondary Amine-Based
Peptidomimetic Inhibitor Of Human Beta-Secretase (Bace)
pdb|3IVH|A Chain A, Design And Synthesis Of Potent Bace-1 Inhibitors With
Cellular Activity: Structure-Activity Relationship Of P1
Substituents
pdb|3IVI|A Chain A, Design And Synthesis Of Potent Bace-1 Inhibitors With
Cellular Activity: Structure-Activity Relationship Of P1
Substituents
pdb|3IVI|B Chain B, Design And Synthesis Of Potent Bace-1 Inhibitors With
Cellular Activity: Structure-Activity Relationship Of P1
Substituents
pdb|3IVI|C Chain C, Design And Synthesis Of Potent Bace-1 Inhibitors With
Cellular Activity: Structure-Activity Relationship Of P1
Substituents
pdb|3NSH|A Chain A, Bace-1 In Complex With Eln475957
pdb|3NSH|B Chain B, Bace-1 In Complex With Eln475957
pdb|3NSH|C Chain C, Bace-1 In Complex With Eln475957
pdb|3N4L|A Chain A, Bace-1 In Complex With Eln380842
pdb|3N4L|B Chain B, Bace-1 In Complex With Eln380842
pdb|3N4L|C Chain C, Bace-1 In Complex With Eln380842
Length = 406
Score = 29.3 bits (64), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 20 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 69
>pdb|2OF0|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 5
pdb|2OHK|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
1- Amino-Isoquinoline
pdb|2OHL|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
2- Aminoquinoline
pdb|2OHM|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
N~3~-Benzylpyridine-2,3-Diamine
pdb|2OHN|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
4- (4-Fluorobenzyl)piperidine
pdb|2OHQ|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 4
pdb|2OHR|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 6a
pdb|2OHS|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 6b
pdb|2OHT|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 7
pdb|2OHU|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 8b
pdb|2OHP|A Chain A, X-ray Crystal Structure Of Beta Secretase Complexed With
Compound 3
Length = 402
Score = 29.3 bits (64), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 31 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 80
>pdb|3TPR|A Chain A, Crystal Structure Of Bace1 Complexed With An Inhibitor
pdb|3UQR|A Chain A, Crystal Structure Of Bace1 With Its Inhibitor
pdb|3UQR|B Chain B, Crystal Structure Of Bace1 With Its Inhibitor
pdb|3UQR|C Chain C, Crystal Structure Of Bace1 With Its Inhibitor
Length = 433
Score = 29.3 bits (64), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 54 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 103
>pdb|4B1C|A Chain A, New Aminoimidazoles As Bace-1 Inhibitors: From Rational
Design To Ab-Lowering In Brain
Length = 375
Score = 29.3 bits (64), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 20 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 69
>pdb|3QI1|A Chain A, Design And Synthesis Of Hydroxyethylamine (Hea) Bace-1
Inhibitors: Prime Side Chromane-Containing Inhibitors
Length = 408
Score = 29.3 bits (64), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 30 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 79
>pdb|2VA5|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 8c
pdb|2VA6|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 24
pdb|2VA7|A Chain A, X-Ray Crystal Structure Of Beta Secretase Complexed With
Compound 27
Length = 455
Score = 29.3 bits (64), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 77 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 126
>pdb|3VV6|A Chain A, Crystal Structure Of Beta Secetase In Complex With
2-Amino-3-Methyl-6- ((1s,
2r)-2-Phenylcyclopropyl)pyrimidin-4(3h)-One
pdb|3VV7|A Chain A, Crystal Structure Of Beta Secetase In Complex With
2-Amino-6-((1s,2r)-
2-(3'-Methoxybiphenyl-3-Yl)cyclopropyl)-3-
Methylpyrimidin-4(3h)-One
pdb|3VV8|A Chain A, Crystal Structure Of Beta Secetase In Complex With
2-Amino-3-Methyl-6-
((1s,
2r)-2-(3'-Methylbiphenyl-4-Yl)cyclopropyl)pyrimidin-
4(3h)-One
Length = 416
Score = 29.3 bits (64), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 37 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 86
>pdb|3IXK|A Chain A, Potent Beta-Secretase 1 Inhibitor
pdb|3IXK|B Chain B, Potent Beta-Secretase 1 Inhibitor
pdb|3IXK|C Chain C, Potent Beta-Secretase 1 Inhibitor
pdb|3KYR|A Chain A, Bace-1 In Complex With A Norstatine Type Inhibitor
pdb|3KYR|B Chain B, Bace-1 In Complex With A Norstatine Type Inhibitor
pdb|3KYR|C Chain C, Bace-1 In Complex With A Norstatine Type Inhibitor
Length = 405
Score = 29.3 bits (64), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 34 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 83
>pdb|2ZJN|A Chain A, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With
N-[1-(5-Chloro-2-Isopropoxy-3-Methoxy-Benzyl)-
Piperidin-4-Yl]-2-(2-Methyl-4-Sulfamoyl-Phenoxy)-
Acetamide
pdb|3H0B|A Chain A, Discovery Of Aminoheterocycles As A Novel Beta-Secretase
Inhibitor Class
pdb|3H0B|B Chain B, Discovery Of Aminoheterocycles As A Novel Beta-Secretase
Inhibitor Class
pdb|3H0B|C Chain C, Discovery Of Aminoheterocycles As A Novel Beta-Secretase
Inhibitor Class
Length = 405
Score = 29.3 bits (64), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 34 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 83
>pdb|3DM6|A Chain A, Beta-Secretase 1 Complexed With Statine-Based Inhibitor
pdb|3DM6|B Chain B, Beta-Secretase 1 Complexed With Statine-Based Inhibitor
pdb|3DM6|C Chain C, Beta-Secretase 1 Complexed With Statine-Based Inhibitor
pdb|3I25|A Chain A, Potent Beta-Secretase 1 Hydroxyethylene Inhibitor
pdb|3I25|B Chain B, Potent Beta-Secretase 1 Hydroxyethylene Inhibitor
pdb|3I25|C Chain C, Potent Beta-Secretase 1 Hydroxyethylene Inhibitor
Length = 406
Score = 29.3 bits (64), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 35 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 84
>pdb|2QU2|A Chain A, Bace1 With Compound 1
pdb|2QU3|A Chain A, Bace1 With Compound 2
pdb|2ZDZ|A Chain A, X-Ray Structure Of Bace-1 In Complex With Compound 3.B.10
pdb|2ZE1|A Chain A, X-Ray Structure Of Bace-1 In Complex With Compound 6g
pdb|3IGB|A Chain A, Bace-1 With Compound 3
pdb|3IN3|A Chain A, Bace1 With Compound 30
pdb|3IN4|A Chain A, Bace1 With Compound 38
pdb|3IND|A Chain A, Bace1 With The Aminohydantoin Compound 29
pdb|3INE|A Chain A, Bace1 With The Aminohydantoin Compound S-34
pdb|3INF|A Chain A, Bace1 With The Aminohydantoin Compound 37
pdb|3INH|A Chain A, Bace1 With The Aminohydantoin Compound R-58
pdb|3LHG|A Chain A, Bace1 In Complex With The Aminohydantoin Compound 4g
pdb|3L38|A Chain A, Bace1 In Complex With The Aminopyridine Compound 44
pdb|3L3A|A Chain A, Bace-1 With The Aminopyridine Compound 32
pdb|3OOZ|A Chain A, Bace1 In Complex With The Aminohydantoin Compound 102
pdb|3S7L|A Chain A, Pyrazolyl And Thienyl Aminohydantoins As Potent Bace1
Inhibitors
pdb|3S7M|A Chain A, Pyrazolyl And Thienyl Aminohydantoins As Potent Bace1
Inhibitors
Length = 415
Score = 29.3 bits (64), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 30 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 79
>pdb|3BRA|A Chain A, Bace-1 Complexed With Compound 1
pdb|3BUF|A Chain A, Bace-1 Complexed With Compound 2
pdb|3BUG|A Chain A, Bace-1 Complexed With Compound 3
pdb|3BUH|A Chain A, Bace-1 Complexed With Compound 4
Length = 409
Score = 29.3 bits (64), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 30 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 79
>pdb|2HIZ|A Chain A, Crystal Structure Of Human Beta-Secretase (Bace) In The
Presence Of An Inhibitor
pdb|2HIZ|B Chain B, Crystal Structure Of Human Beta-Secretase (Bace) In The
Presence Of An Inhibitor
pdb|2HIZ|C Chain C, Crystal Structure Of Human Beta-Secretase (Bace) In The
Presence Of An Inhibitor
pdb|2P83|A Chain A, Potent And Selective Isophthalamide S2 Hydroxyethylamine
Inhibitor Of Bace1
pdb|2P83|B Chain B, Potent And Selective Isophthalamide S2 Hydroxyethylamine
Inhibitor Of Bace1
pdb|2P83|C Chain C, Potent And Selective Isophthalamide S2 Hydroxyethylamine
Inhibitor Of Bace1
Length = 455
Score = 29.3 bits (64), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 77 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 126
>pdb|1TQF|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Inhibitor
pdb|2B8L|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Inhibitor
pdb|2B8V|A Chain A, Crystal Structure Of Human Beta-Secretase Complexed With
L- L000430,469
pdb|2IRZ|A Chain A, Crystal Structure Of Human Beta-Secretase Complexed With
Inhibitor
pdb|2IS0|A Chain A, Crystal Structure Of Human Beta-Secretase Complexed With
Inhibitor
pdb|2PH6|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Inhibitor
pdb|2OAH|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Inhibitor
pdb|2P8H|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Inhibitor
pdb|2NTR|A Chain A, Crystal Structure Of Human Bace-1 Bound To Inhibitor
pdb|2PH8|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Inhibitor
pdb|2QZK|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
I21
pdb|2ZJM|A Chain A, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With
N-[1-(5-Chloro-2-Isopropoxy-3-Methoxy-Benzyl)-
Piperidin-4-Yl]-2-(4-Sulfamoyl-Phenoxy)-Acetamide
pdb|3FKT|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Spiropiperdine Iminohydantoin Inhibitor
Length = 405
Score = 29.3 bits (64), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 34 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 83
>pdb|2Q11|A Chain A, Structure Of Bace Complexed To Compound 1
pdb|2Q11|B Chain B, Structure Of Bace Complexed To Compound 1
pdb|2Q11|C Chain C, Structure Of Bace Complexed To Compound 1
Length = 388
Score = 29.3 bits (64), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 17 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 66
>pdb|3EXO|A Chain A, Crystal Structure Of Bace1 Bound To Inhibitor
Length = 413
Score = 29.3 bits (64), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 34 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 83
>pdb|1YM4|A Chain A, Crystal Structure Of Human Beta Secretase Complexed With
Nvp-Amk640
pdb|1YM4|B Chain B, Crystal Structure Of Human Beta Secretase Complexed With
Nvp-Amk640
pdb|1YM4|C Chain C, Crystal Structure Of Human Beta Secretase Complexed With
Nvp-Amk640
pdb|3K5D|A Chain A, Crystal Structure Of Bace-1 In Complex With Ahm178
pdb|3K5D|B Chain B, Crystal Structure Of Bace-1 In Complex With Ahm178
pdb|3K5D|C Chain C, Crystal Structure Of Bace-1 In Complex With Ahm178
pdb|3MSK|A Chain A, Fragment Based Discovery And Optimisation Of Bace-1
Inhibitors
pdb|3MSL|A Chain A, Fragment Based Discovery And Optimisation Of Bace-1
Inhibitors
pdb|3S2O|A Chain A, Fragment Based Discovery And Optimisation Of Bace-1
Inhibitors
pdb|4D85|A Chain A, Crystal Structure Of Human Beta Secretase In Complex With
Nvp-Bvi151
Length = 408
Score = 28.9 bits (63), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 30 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 79
>pdb|2ZHR|A Chain A, Crystal Structure Of Bace1 In Complex With Om99-2 At Ph
5.0
pdb|2ZHR|B Chain B, Crystal Structure Of Bace1 In Complex With Om99-2 At Ph
5.0
pdb|2ZHS|A Chain A, Crystal Structure Of Bace1 At Ph 4.0
pdb|2ZHT|A Chain A, Crystal Structure Of Bace1 At Ph 4.5
pdb|2ZHU|A Chain A, Crystal Structure Of Bace1 At Ph 5.0
pdb|2ZHV|A Chain A, Crystal Structure Of Bace1 At Ph 7.0
Length = 411
Score = 28.9 bits (63), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 32 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 81
>pdb|2Q15|A Chain A, Structure Of Bace Complexed To Compound 3a
Length = 385
Score = 28.9 bits (63), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 14 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 63
>pdb|2ZJJ|A Chain A, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With 4-(4-Fluoro-Benzyl)-Piperazine-2-Carboxylic
Acid (2-Mercapto-Ethyl)- Amide
Length = 405
Score = 28.9 bits (63), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 34 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 83
>pdb|3L58|A Chain A, Structure Of Bace Bound To Sch589432
pdb|3L58|B Chain B, Structure Of Bace Bound To Sch589432
pdb|3L59|A Chain A, Structure Of Bace Bound To Sch710413
pdb|3L59|B Chain B, Structure Of Bace Bound To Sch710413
pdb|3L5B|A Chain A, Structure Of Bace Bound To Sch713601
pdb|3L5B|B Chain B, Structure Of Bace Bound To Sch713601
pdb|3L5C|A Chain A, Structure Of Bace Bound To Sch723871
pdb|3L5C|B Chain B, Structure Of Bace Bound To Sch723871
pdb|3L5D|A Chain A, Structure Of Bace Bound To Sch723873
pdb|3L5D|B Chain B, Structure Of Bace Bound To Sch723873
pdb|3L5E|A Chain A, Structure Of Bace Bound To Sch736062
pdb|3L5E|B Chain B, Structure Of Bace Bound To Sch736062
pdb|3L5F|A Chain A, Structure Of Bace Bound To Sch736201
pdb|3L5F|B Chain B, Structure Of Bace Bound To Sch736201
pdb|4DJU|A Chain A, Structure Of Bace Bound To
2-Imino-3-Methyl-5,5-Diphenylimidazolidin- 4-One
pdb|4DJU|B Chain B, Structure Of Bace Bound To
2-Imino-3-Methyl-5,5-Diphenylimidazolidin- 4-One
pdb|4DJV|A Chain A, Structure Of Bace Bound To
2-Imino-5-(3'-Methoxy-[1,1'-Biphenyl]-3-
Yl)-3-Methyl-5-Phenylimidazolidin-4-One
pdb|4DJV|B Chain B, Structure Of Bace Bound To
2-Imino-5-(3'-Methoxy-[1,1'-Biphenyl]-3-
Yl)-3-Methyl-5-Phenylimidazolidin-4-One
pdb|4DJW|A Chain A, Structure Of Bace Bound To
2-Imino-3-Methyl-5-Phenyl-5-(3-(Pyridin-3-
Yl)phenyl)imidazolidin-4-One
pdb|4DJW|B Chain B, Structure Of Bace Bound To
2-Imino-3-Methyl-5-Phenyl-5-(3-(Pyridin-3-
Yl)phenyl)imidazolidin-4-One
pdb|4DJX|A Chain A, Structure Of Bace Bound To
5-(3-(5-Chloropyridin-3-Yl)phenyl)-5-
Cyclopropyl-2-Imino-3-Methylimidazolidin-4-One
pdb|4DJX|B Chain B, Structure Of Bace Bound To
5-(3-(5-Chloropyridin-3-Yl)phenyl)-5-
Cyclopropyl-2-Imino-3-Methylimidazolidin-4-One
pdb|4DJY|A Chain A, Structure Of Bace Bound To
(R)-5-Cyclopropyl-2-Imino-3-Methyl-5-(3-(5-
(Prop-1-Yn-1-Yl)pyridin-3-Yl)phenyl)imidazolidin-4-One
pdb|4DJY|B Chain B, Structure Of Bace Bound To
(R)-5-Cyclopropyl-2-Imino-3-Methyl-5-(3-(5-
(Prop-1-Yn-1-Yl)pyridin-3-Yl)phenyl)imidazolidin-4-One
pdb|4H1E|A Chain A, Structure Of Bace-1 Bound To
(7ar)-6-Benzoyl-7a-(4-(3-Cyanophenyl)
Thiophen-2-Yl)-3-Methyl-4-Oxohexahydro-1h-Pyrrolo[3,
4-D]pyrimidin- 2(3h)-Iminium
pdb|4H1E|B Chain B, Structure Of Bace-1 Bound To
(7ar)-6-Benzoyl-7a-(4-(3-Cyanophenyl)
Thiophen-2-Yl)-3-Methyl-4-Oxohexahydro-1h-Pyrrolo[3,
4-D]pyrimidin- 2(3h)-Iminium
pdb|4H3J|A Chain A, Structure Of Bace Bound To
2-Fluoro-5-(5-(2-Imino-3-Methyl-4-Oxo-6-
Phenyloctahydro-1h-Pyrrolo[3,
4-D]pyrimidin-7a-Yl)thiophen-2-Yl) Benzonitrile
pdb|4H3J|B Chain B, Structure Of Bace Bound To
2-Fluoro-5-(5-(2-Imino-3-Methyl-4-Oxo-6-
Phenyloctahydro-1h-Pyrrolo[3,
4-D]pyrimidin-7a-Yl)thiophen-2-Yl) Benzonitrile
pdb|4HA5|A Chain A, Structure Of Bace Bound To
(S)-3-(5-(2-Imino-1,4-Dimethyl-6-
Oxohexahydropyrimidin-4-Yl)thiophen-3-Yl)benzonitrile
pdb|4HA5|B Chain B, Structure Of Bace Bound To
(S)-3-(5-(2-Imino-1,4-Dimethyl-6-
Oxohexahydropyrimidin-4-Yl)thiophen-3-Yl)benzonitrile
pdb|4H3F|A Chain A, Structure Of Bace Bound To
3-(5-((7ar)-2-Imino-6-(6-Methoxypyridin-2-
Yl)-3-Methyl-4-Oxooctahydro-1h-Pyrrolo[3,
4-D]pyrimidin-7a-Yl) Thiophen-3-Yl)benzonitrile
pdb|4H3F|B Chain B, Structure Of Bace Bound To
3-(5-((7ar)-2-Imino-6-(6-Methoxypyridin-2-
Yl)-3-Methyl-4-Oxooctahydro-1h-Pyrrolo[3,
4-D]pyrimidin-7a-Yl) Thiophen-3-Yl)benzonitrile
pdb|4H3G|A Chain A, Structure Of Bace Bound To
2-((7ar)-7a-(4-(3-Cyanophenyl)thiophen-2-
Yl)-2-Imino-3-Methyl-4-Oxohexahydro-1h-Pyrrolo[3,
4-D]pyrimidin-6(2h)- Yl)nicotinonitrile
pdb|4H3G|B Chain B, Structure Of Bace Bound To
2-((7ar)-7a-(4-(3-Cyanophenyl)thiophen-2-
Yl)-2-Imino-3-Methyl-4-Oxohexahydro-1h-Pyrrolo[3,
4-D]pyrimidin-6(2h)- Yl)nicotinonitrile
pdb|4H3I|A Chain A, Structure Of Bace Bound To
3-(5-((7ar)-2-Imino-6-(3-Methoxypyridin-2-
Yl)-3-Methyl-4-Oxooctahydro-1h-Pyrrolo[3,
4-D]pyrimidin-7a-Yl) Thiophen-3-Yl)benzonitrile
pdb|4H3I|B Chain B, Structure Of Bace Bound To
3-(5-((7ar)-2-Imino-6-(3-Methoxypyridin-2-
Yl)-3-Methyl-4-Oxooctahydro-1h-Pyrrolo[3,
4-D]pyrimidin-7a-Yl) Thiophen-3-Yl)benzonitrile
Length = 414
Score = 28.9 bits (63), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 35 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 84
>pdb|3HVG|A Chain A, Structure Of Bace (Beta Secretase) In Complex With Ev0
pdb|3HVG|B Chain B, Structure Of Bace (Beta Secretase) In Complex With Ev0
pdb|3HVG|C Chain C, Structure Of Bace (Beta Secretase) In Complex With Ev0
pdb|3HW1|A Chain A, Structure Of Bace (Beta Secretase) In Complex With Ligand
Ev2
pdb|3HW1|B Chain B, Structure Of Bace (Beta Secretase) In Complex With Ligand
Ev2
pdb|3HW1|C Chain C, Structure Of Bace (Beta Secretase) In Complex With Ligand
Ev2
pdb|3MSJ|A Chain A, Structure Of Bace (Beta Secretase) In Complex With
Inhibitor
pdb|3MSJ|B Chain B, Structure Of Bace (Beta Secretase) In Complex With
Inhibitor
pdb|3MSJ|C Chain C, Structure Of Bace (Beta Secretase) In Complex With
Inhibitor
Length = 411
Score = 28.9 bits (63), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 33 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 82
>pdb|2ZJK|A Chain A, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With 4-(4-Fluoro-Benzyl)-Piperazine-2-Carboxylic
Acid(3-Mercapto-Propyl)-Amide
pdb|2ZJK|B Chain B, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With 4-(4-Fluoro-Benzyl)-Piperazine-2-Carboxylic
Acid(3-Mercapto-Propyl)-Amide
pdb|2ZJK|C Chain C, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With 4-(4-Fluoro-Benzyl)-Piperazine-2-Carboxylic
Acid(3-Mercapto-Propyl)-Amide
Length = 405
Score = 28.9 bits (63), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 34 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 83
>pdb|2ZJI|A Chain A, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With
N-[1-(2,
6-Dimethoxy-Benzyl)-Piperidin-4-Yl]-4-Mercapto-
Butyramide
Length = 405
Score = 28.9 bits (63), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 34 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 83
>pdb|2ZJH|A Chain A, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With
N-(1-Benzyl-Piperidin-4-Yl)-4-Mercapto-Butyramide
pdb|2ZJL|A Chain A, Crystal Structure Of The Human Bace1 Catalytic Domain In
Complex With
N-[1-(5-Bromo-2,3-Dimethoxy-Benzyl)-Piperidin-
4-Yl]-4-Mercapto-Butyramide
Length = 405
Score = 28.9 bits (63), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 34 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 83
>pdb|1W50|A Chain A, Apo Structure Of Bace (beta Secretase)
pdb|1W51|A Chain A, Bace (Beta Secretase) In Complex With A Nanomolar Non-
Peptidic Inhibitor
pdb|3RSV|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
(R)-3-(2-Amino-6-
O-Tolylquinolin-3-Yl)-N-((R)-2,
2-Dimethyltetrahydro-2h-Pyran-4-Yl)-2- Methylpropanamide
pdb|3RSX|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
6-(Thiophen-3- Yl)quinolin-2-Amine
pdb|3RTH|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
6-(2-(3,3- Dimethylbut-1-Ynyl)phenyl)quinolin-2-Amine
pdb|3RTM|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With 3-(2-
Aminoquinolin-3-Yl)-N-Cyclohexyl-N-Methylpropanamide
pdb|3RTN|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
3-(2-Amino-6-O-
Tolylquinolin-3-Yl)-N-Cyclohexylpropanamide
pdb|3RU1|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With 3-(2-
Aminoquinolin-3-Yl)-N-(Cyclohexylmethyl)propanamide
pdb|3RVI|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
2-((2-Amino-6-O-
Tolylquinolin-3-Yl)methyl)-N-
(Cyclohexylmethyl)pentanamide
pdb|4ACU|A Chain A, Aminoimidazoles As Bace-1 Inhibitors. X-Ray Crystal
Structure Of Beta Secretase Complexed With Compound 14
pdb|4ACX|A Chain A, Aminoimidazoles As Bace-1 Inhibitors. X-Ray Crystal
Structure Of Beta Secretase Complexed With Compound 23
pdb|4DH6|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
(2r)-N-((2s,3r)-
1-(Benzo[d][1,
3]dioxol-5-Yl)-3-Hydroxy-4-((S)-6'-Neopentyl-3',4'-
Dihydrospiro[cyclobutane-1,2'-Pyrano[2,
3-B]pyridine]-4'-Ylamino)
Butan-2-Yl)-2-Methoxypropanamide
pdb|4FRI|A Chain A, Crystal Structure Of Bace1 In Complex With Biarylspiro
Aminooxazoline 6
pdb|4FRJ|A Chain A, Crystal Structure Of Bace1 In Complex With Aminooxazoline
Xanthene 9l
pdb|4FRK|A Chain A, Crystal Structure Of Bace1 In Complex With Aminooxazoline
Xanthene 11a
pdb|4DI2|A Chain A, Crystal Structure Of Bace1 In Complex With
Hydroxyethylamine Inhibitor 37
pdb|4DI2|B Chain B, Crystal Structure Of Bace1 In Complex With
Hydroxyethylamine Inhibitor 37
pdb|4DI2|C Chain C, Crystal Structure Of Bace1 In Complex With
Hydroxyethylamine Inhibitor 37
pdb|4DUS|A Chain A, Structure Of Bace-1 (Beta-Secretase) In Complex With
N-((2s,3r)-1-(4-
Fluorophenyl)-3-Hydroxy-4-((6'-Neopentyl-3',4'-
Dihydrospiro[cyclobutane-1,2'-Pyrano[2,
3-B]pyridin]-4'-Yl)amino) Butan-2-Yl)acetamide
pdb|4AZY|A Chain A, Design And Synthesis Of Bace1 Inhibitors With In Vivo
Brain Reduction Of Beta-Amyloid Peptides (Compound 10)
pdb|4B00|A Chain A, Design And Synthesis Of Bace1 Inhibitors With In Vivo
Brain Reduction Of Beta-Amyloid Peptides (Compound
(R)-41)
pdb|4B05|A Chain A, Preclinical Characterization Of Azd3839, A Novel Clinical
Candidate Bace1 Inhibitor For The Treatment Of Alzheimer
Disease
Length = 411
Score = 28.9 bits (63), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 33 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 82
>pdb|3CKP|A Chain A, Crystal Structure Of Bace-1 In Complex With Inhibitor
pdb|3CKP|B Chain B, Crystal Structure Of Bace-1 In Complex With Inhibitor
pdb|3CKP|C Chain C, Crystal Structure Of Bace-1 In Complex With Inhibitor
pdb|3CKR|A Chain A, Crystal Structure Of Bace-1 In Complex With Inhibitor
pdb|3CKR|B Chain B, Crystal Structure Of Bace-1 In Complex With Inhibitor
pdb|3CKR|C Chain C, Crystal Structure Of Bace-1 In Complex With Inhibitor
pdb|4FSL|A Chain A, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Db-Mut) Complex With N-(N-(4-
Acetamido-3-Chloro-5-Methylbenzyl) Carbamimidoyl)-3-(4-
Methoxyphenyl)-5-Methyl-4-Isothiazolecarboxamide
pdb|4FSL|B Chain B, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Db-Mut) Complex With N-(N-(4-
Acetamido-3-Chloro-5-Methylbenzyl) Carbamimidoyl)-3-(4-
Methoxyphenyl)-5-Methyl-4-Isothiazolecarboxamide
pdb|4FSL|D Chain D, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Db-Mut) Complex With N-(N-(4-
Acetamido-3-Chloro-5-Methylbenzyl) Carbamimidoyl)-3-(4-
Methoxyphenyl)-5-Methyl-4-Isothiazolecarboxamide
pdb|4FSL|E Chain E, Crystal Structure Of Beta-Site App-Cleaving Enzyme 1
(Bace-Db-Mut) Complex With N-(N-(4-
Acetamido-3-Chloro-5-Methylbenzyl) Carbamimidoyl)-3-(4-
Methoxyphenyl)-5-Methyl-4-Isothiazolecarboxamide
Length = 412
Score = 28.9 bits (63), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 33 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 82
>pdb|2VIE|A Chain A, Human Bace-1 In Complex With
N-((1s,2r)-1-Benzyl-2-Hydroxy-
3-((1,1,
5-Trimethylhexyl)amino)propyl)-3-(Ethylamino)-5-(2-
Oxopyrrolidin-1-Yl)benzamide
pdb|2VIJ|A Chain A, Human Bace-1 In Complex With
3-(1,1-Dioxidotetrahydro-2h-1,
2-Thiazin-2-Yl)-5-(Ethylamino)-N-((1s,2r)-2-Hydroxy-1-(
Phenylmethyl)-3-(1,2,3,4-Tetrahydro-1-Naphthalenylamino)
Propyl)benzamide
pdb|2VIY|A Chain A, Human Bace-1 In Complex With N-((1s,2r)-3-(((1s)-2-(
Cyclohexylamino)-1-Methyl-2-Oxoethyl)amino)-2-Hydroxy-1-
( Phenylmethyl)propyl)-3-(Pentylsulfonyl)benzamide
pdb|2VIZ|A Chain A, Human Bace-1 In Complex With N-((1s,2r)-3-(((1s)-2-(
Cyclohexylamino)-1-methyl-2-oxoethyl)amino)-2-hydroxy-1-
(
Phenylmethyl)propyl)-3-(2-oxo-1-pyrrolidinyl)-5-
(propyloxy) Benzamide
pdb|2VJ6|A Chain A, Human Bace-1 In Complex With N-((1s,2r)-3-(((1s)-2-(
Cyclohexylamino)-1-Methyl-2-Oxoethyl)amino)-2-Hydroxy-1-
( Phenylmethyl)propyl)-3-(Ethylamino)-5-(2-Oxo-1-
Pyrrolidinyl)benzamide
pdb|2VJ7|A Chain A, Human Bace-1 In Complex With 3-(Ethylamino)-N-((1s,2r)-2-
Hydroxy-1-(Phenylmethyl)-3-(((3-(Trifluoromethyl)phenyl)
Methyl)amino)propyl)-5-(2-Oxo-1-Pyrrolidinyl)benzamide
pdb|2VJ9|A Chain A, Human Bace-1 In Complex With
N-((1s,2r)-3-(Cyclohexylamino)-
2-Hydroxy-1-(Phenylmethyl)propyl)-3-(Ethylamino)-5-(2-
Oxo- 1-Pyrrolidinyl)benzamide
pdb|2VNM|A Chain A, Human Bace-1 In Complex With
3-(1,1-Dioxidotetrahydro-2h-1,
2-Thiazin-2-Yl)-5-(Ethylamino)-N-((1s,2r)-2-Hydroxy-1-(
Phenylmethyl)-3-(((3-
(Trifluoromethyl)phenyl)methyl)amino) Propyl)benzamide
pdb|2VNN|A Chain A, Human Bace-1 In Complex With
7-Ethyl-N-((1s,2r)-2-Hydroxy-1-
(Phenylmethyl)-3-(((3-
(Trifluoromethyl)phenyl)methyl)amino)
Propyl)-1-Methyl-3,4-Dihydro-1h-(1,2,5)thiadiazepino(3,
4,5- Hi)indole-9-Carboxamide 2,2-Dioxide
pdb|2WF4|A Chain A, Human Bace-1 In Complex With
6-Ethyl-1-Methyl-N-((1s)-2-Oxo-
1-(Phenylmethyl)-3-(Tetrahydro-2h-Pyran-4-
Ylamino)propyl)-
1,3,4,6-Tetrahydro(1,2)thiazepino(5,4,3-Cd)indole-8-
Carboxamide 2,2-Dioxide
pdb|2WEZ|A Chain A, Human Bace-1 In Complex With
1-Ethyl-N-((1s,2r)-2-Hydroxy-3-
(((3-(Methyloxy)phenyl)methyl)amino)-1-(Phenylmethyl)
Propyl)-4-(2-Oxo-1-Pyrrolidinyl)-1h-Indole-6-Carboxamide
pdb|2WF0|A Chain A, Human Bace-1 In Complex With
4-Ethyl-N-((1s,2r)-2-Hydroxy-1-
(Phenylmethyl)-3-(((3-
(Trifluoromethyl)phenyl)methyl)amino)
Propyl)-8-(2-Oxo-1-Pyrrolidinyl)-6-Quinolinecarboxamide
pdb|2WF1|A Chain A, Human Bace-1 In Complex With
7-Ethyl-N-((1s,2r)-2-Hydroxy-3-
(((3-(Methyloxy)phenyl(Methyl)amino)-1-(Phenylmethyl)
Propyl)-1-Methyl-3,4-Dihydro-1h-(1,2,5)thiadiazepino(3,
4,5- Hi)indole-9-Carboxamide 2,2-Dioxide
pdb|2WF2|A Chain A, Human Bace-1 In Complex With
8-Ethyl-N-((1s,2r)-2-Hydroxy-3-
(((3-(Methyloxy)phenyl)methyl)amino)-1-(Phenylmethyl)
Propyl)-1-Methyl-3,4,7,8-Tetrahydro-1h,6h-(1,2,5)
Thiadiazepino(5,4,3-De)quinoxaline-10-Carboxamide 2,2-
Dioxide
pdb|2WF3|A Chain A, Human Bace-1 In Complex With 6-(Ethylamino)-N-((1s,2r)-2-
Hydroxy-3-(((3-(Methyloxy)phenyl)methyl)amino)-1-(
Phenylmethyl)propyl)-1-Methyl-1,3,4,5-Tetrahydro-2,1-
Benzothiazepine-8-Carboxamide 2,2-Dioxide
pdb|2XFI|A Chain A, Human Bace-1 In Complex With N-((1s,2r)-3-(((1s)-2-(
Cyclohexylamino)-1-Methyl-2-Oxoethyl)amino)-2-Hydroxy-1-
( Phenylmethyl)propyl)-3-((Methylsulfonyl)(Phenyl)amino)
Benzamide
pdb|2XFJ|A Chain A, Human Bace-1 In Complex With N-((1s,2r)-3-(((1s)-2-(
Cyclohexylamino)-1-Methyl-2-Oxoethyl)amino)-2-Hydroxy-1-
( Phenylmethyl)propyl)-3-(Ethylamino)-5-(2-Oxo-1-
Pyrrolidinyl)benzamide
pdb|2XFK|A Chain A, Human Bace-1 In Complex With N-((1s,2r)-3-(((1s)-2-(
Cyclohexylamino)-1-Methyl-2-Oxoethyl)amino)-2-Hydroxy-1-
(
Phenylmethyl)propyl)-3-(Ethylamino)-5-((Methylsulfonyl)(
Phenyl)amino)benzamide
Length = 392
Score = 28.9 bits (63), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 6/56 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSL 146
Y + +++G+PP + DTGS P P Y Q ++SSTY+ L
Sbjct: 15 YYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQR------QLSSTYRDL 64
>pdb|2EWY|A Chain A, Crystal Structure Of Human Bace2 In Complex With A
Hydroxyethylenamine Transition-State Inhibitor
pdb|2EWY|B Chain B, Crystal Structure Of Human Bace2 In Complex With A
Hydroxyethylenamine Transition-State Inhibitor
pdb|2EWY|C Chain C, Crystal Structure Of Human Bace2 In Complex With A
Hydroxyethylenamine Transition-State Inhibitor
pdb|2EWY|D Chain D, Crystal Structure Of Human Bace2 In Complex With A
Hydroxyethylenamine Transition-State Inhibitor
Length = 383
Score = 28.9 bits (63), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 19/55 (34%), Positives = 25/55 (45%), Gaps = 6/55 (10%)
Query: 91 YLIRISIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKS 145
Y + + IGTPP + + DTGS P Y FD + SSTY+S
Sbjct: 15 YYLEMLIGTPPQKLQILVDTGSSNFAVAGTPHSYIDTY------FDTERSSTYRS 63
>pdb|2EER|A Chain A, Structural Study Of Project Id St2577 From Sulfolobus
Tokodaii Strain7
pdb|2EER|B Chain B, Structural Study Of Project Id St2577 From Sulfolobus
Tokodaii Strain7
Length = 347
Score = 28.1 bits (61), Expect = 7.1, Method: Compositional matrix adjust.
Identities = 24/96 (25%), Positives = 42/96 (43%), Gaps = 6/96 (6%)
Query: 201 GITFGCGTNNGGLFNSKTTGIVGLGGGDISLISQMRTTIAGNQRLGVSTPDIVIDSDPTG 260
G+T L SKT ++G GGG ++ Q+ ++G +GV + +++
Sbjct: 156 GVTTYRAVRKASLDPSKTLVVIGAGGGLGTMAIQIAKAVSGATIIGVDVREEALEAAKRA 215
Query: 261 SLELCYSFNSLSQVPEVTIHF----RGADVKLSRSN 292
+ Y N+ SQ P I +GAD + +N
Sbjct: 216 GAD--YVINASSQDPVSEIRRITQGKGADAVIDLNN 249
>pdb|1QS8|A Chain A, Crystal Structure Of The P. Vivax Aspartic Proteinase
Plasmepsin Complexed With The Inhibitor Pepstatin A
pdb|1QS8|B Chain B, Crystal Structure Of The P. Vivax Aspartic Proteinase
Plasmepsin Complexed With The Inhibitor Pepstatin A
Length = 329
Score = 28.1 bits (61), Expect = 7.3, Method: Compositional matrix adjust.
Identities = 32/137 (23%), Positives = 61/137 (44%), Gaps = 25/137 (18%)
Query: 96 SIGTPPTERLAVADTGSDLIWTQCEPCPPSQCYMQDSPLFDPKMSSTYKSLPCSSSQCAS 155
+G + + + DTGS +W + C S C +++ L+D S +Y
Sbjct: 23 EVGDNHQKFMLIFDTGSANLWVPSKKCNSSGCSIKN--LYDSSKSKSY------------ 68
Query: 156 LNQKSCSGVNCQYSVSYGDGSFSNGNLATETVTLGSTTGQAVALPGITFGCGTNNGGLFN 215
+K + V+ ++YG G+ G + + VTLG + + I + +++
Sbjct: 69 --EKDGTKVD----ITYGSGTVK-GFFSKDLVTLGHLSMPYKFIEVID---TDDLEPIYS 118
Query: 216 S-KTTGIVGLGGGDISL 231
S + GI+GLG D+S+
Sbjct: 119 SVEFDGILGLGWKDLSI 135
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.318 0.134 0.402
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 10,062,366
Number of Sequences: 62578
Number of extensions: 414058
Number of successful extensions: 1090
Number of sequences better than 100.0: 115
Number of HSP's better than 100.0 without gapping: 49
Number of HSP's successfully gapped in prelim test: 66
Number of HSP's that attempted gapping in prelim test: 1008
Number of HSP's gapped (non-prelim): 122
length of query: 345
length of database: 14,973,337
effective HSP length: 100
effective length of query: 245
effective length of database: 8,715,537
effective search space: 2135306565
effective search space used: 2135306565
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 52 (24.6 bits)